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ABSTRACT
A series of experiments were conducted to determine the effects of on-arrival vs.
delayed respiratory vaccination and exposure to persistently infected bovine viral
diarrhea virus challenge on health, gain performance, and physiological and
immunological measurements in newly received stocker cattle. Two experiments
evaluated timing (d 0 vs. 14) of respiratory, clostridial, or both vaccinations in newly
received stocker calves during stress-induced immunosuppression. In Exp. 1, calves
receiving 14-d delayed vaccination of a pentavalent modified-live respiratory virus
(MLV) vaccine had greater ADG during the 42-d receiving period and antibody titers
against infectious bovine rhinotracheitis on d 42; however, morbidity rate did not differ.
In the second study, stress indicated by serum cortisol concentration and
neutrophil:lymphocyte ratio was greatest on d 0; nevertheless, no differences in
performance or morbidity were observed for vaccination treatments. Both studies
provided evidence that on-arrival administration of a pentavalent MLV respiratory
vaccine to immunocompromised cattle does not mitigate clinical bovine respiratory
disease (BRD) or improve animal performance because the majority of clinical
respiratory disease for both studies occurred during the first 14-d and morbidity rate was
not different when calves were vaccinated on d 0 vs. 14.
A third experiment was performed to determine the effects of weaning
management and subsequent exposure to persistently infected (PI) bovine viral diarrhea
virus (BVDV) challenge on health, performance, bovine viral diarrhea virus titers,
peripheral blood leukocytes, and inflammatory cytokines. The objective was to compare
preconditioned (PC) or auction market (AM) origin cattle, with (PI) or without (CON)

continuous exposure to PI-BVDV type 1b challenge in a 2 × 2 factorial arrangement to
evaluate main effects of management, exposure, and their interaction on health
parameters and growth performance during a 42-d receiving trial. Preconditioned calves
that were vaccinated, castrated, and weaned at their origin ranch had greater gain
performance and reduced BRD morbidity compared to AM calves with unknown history.
Furthermore, PC cattle had greater antibody titers to BVDV type 1a on d 0, and
neutrophil:lymphocyte ratio and platelet count were lower during the 42-d receiving
period. Exposure to PI-BVDV challenge reduced gain from d 28 to 42, perhaps due to an
additive effect of continuous immune stimulation resulting in nutrients being
preferentially utilized for immune pathways rather than tissue deposition. A treatment
interaction was observed for the percentage of chronically ill animals; AMPI had the
greatest number of chronically ill calves (7.6%), AMCON was intermediate (1.1%), and
PCCON and PCPI were least (0.4 and 0.3%, respectively). Exposure to PI-BVDV
challenge increased serum TNF-α concentrations, and IFN-γ concentrations on d 14 and
were greatest for AMPI, intermediate for PCPI, and least for AMCON and PCCON. The
increased cytokine concentrations associated with PI-BVDV exposure illustrate a more
stimulated immune response which has implications for animal health due to taxation of
the immune system and growth due to a homeorhetic response in which nutrients may be
preferentially shifted towards immune function rather than tissue growth.

This dissertation is approved for
Recommendation to the
Graduate Council
Dissertation Director:

____________________________________
Dr. Elizabeth B. Kegley

Dissertation Committee:

_____________________________________
Dr. Paul A. Beck

_____________________________________
Dr. Gisela F. Erf

_____________________________________
Dr. Keith S. Lusby

_____________________________________
Dr. Jeremy G. Powell

DISSERTATION DUPLICATION RELEASE
I hereby authorize the University of Arkansas Libraries to duplicate this
dissertation when needed for research and/or scholarship.

Agreed
John Thomas Richeson

Refused
John Thomas Richeson

ACKNOWLEDGEMENTS
There are many who greatly deserve acknowledgement for their contributions to my
research and education in pursuit of a Ph.D. at the University of Arkansas. First, this
research would not have been possible without cooperation and input from several cattle
producers including Miller Poultry & Cattle, Gallery Ranch, Arkansas Dept. of
Corrections, and Pendergrass Cattle Company, among others. Pete Hornsby and
experiment station personnel, with their expertise in animal care and management, were
crucial for the successful completion of this research. In the laboratory, Doug Galloway,
Patricia Federico, Dr. Julia Ridpath, and Dr. Randy Sacco provided their generous
expertise, training and assistance with analyses. Furthermore, thank you to Boehringer
Ingelheim Vetmedica, Inc., for providing financial and product support in these research
endeavors.
An exceptional appreciation must be given to Dr. Beth Kegley, the director of this
dissertation, for her endless patience, encouragement and mentorship. Also, Drs. Paul
Beck, Gisela Erf, Keith Lusby, and Jeremy Powell with their guidance, teaching, and
committee service are greatly admired. I would also express thanks to fellow graduate
students, staff, and other faculty for their valuable assistance and friendship.
Finally, a sincere gratitude is expressed to my fiancée Ashleigh for her support and
understanding. Also thank you to my family, friends, and loved ones, particularly my
mother, a life-long educator. Her guidance and encouragement are responsible for my
achievement and success in career and education.

vi

TABLE OF CONTENTS
CHAPTER I: INTRODUCTION..................................................................................... 1
CHAPTER II: REVIEW OF LITERATURE .................................................................. 3
Overview of Bovine Respiratory Disease in the US ........................................... 3
Effects of Physiological Stress on Stocker and Feedlot Cattle ............................ 6
Identified Stressors in Beef Cattle Management ............................................... 13
Effects of Preconditioning Management on Bovine Respiratory Disease and
Growth Performance ............................................................................. 18
Overview of Bovine Viral Diarrhea Virus and its role in Bovine Respiratory
Disease .................................................................................................. 20
Conclusions from the Literature ....................................................................... 26
Literature Cited ................................................................................................. 27
CHAPTER III: EFFECTS OF ON-ARRIVAL VERSUS DELAYED MODIFIED LIVE
VIRUS VACCINATION ON HEALTH, PERFORMANCE AND
SERUM INFECTIOUS BOVINE RHINOTRACHEITIS TITERS OF
NEWLY RECEIVED BEEF CALVES .............................................. 35
Abstract ........................................................................................................... 36
Introduction ..................................................................................................... 37
Materials and Methods .................................................................................... 38
Results and Discussion..................................................................................... 43
Literature Cited ............................................................................................... 47
CHAPTER IV: EFFECTS OF ON-ARRIVAL VERSUS DELAYED CLOSTRIDIAL
OR MODIFIED LIVE RESPIRATORY VACCINATIONS ON
HEALTH, PERFORMANCE, BOVINE VIRAL DIARRHEA VIRUS
TYPE I TITERS, AND STRESS AND IMMUNE MEASURES OF
NEWLY RECEIVED BEEF CALVES ............................................. 52
Abstract ........................................................................................................... 53
Introduction .................................................................................................... 54
Materials and Methods ................................................................................... 55
Results and Discussion ................................................................................... 60
Literature Cited ............................................................................................... 67
CHAPTER V: WEANING MANAGEMENT OF NEWLY RECEIVED BEEF CALVES
WITH OR WITHOUT CONTINUOUS EXPOSURE TO A
PERSISTENTLY INFECTED BOVINE VIRAL DIARRHEA VIRUS
CALF: EFFECTS ON HEALTH, PERFORMANCE, BOVINE VIRAL
DIARRHEA VIRUS TITERS, AND PERIPHERAL BLOOD
LEUKOCYTES ................................................................................. 78

vii

Abstract ......................................................................................................... 79
Introduction ................................................................................................... 80
Materials and Methods .................................................................................. 81
Results and Discussion .................................................................................. 89
Literature Cited ............................................................................................ 100
CHAPTER VI: WEANING MANAGEMENT OF NEWLY RECEIVED BEEF
CALVES WITH OR WITHOUT CONTINUOUS EXPOSURE TO A
PERSISTENTLY INFECTED BOVINE VIRAL DIARRHEA VIRUS
CALF: EFFECTS ON SERUM PROINFLAMMATORY CYTOKINE
CONCENTRATIONS AND PERIPHERAL BLOOD LEUKOCYTES
.......................................................................................................... 118
Abstract ........................................................................................................ 119
Introduction ................................................................................................. 120
Materials and Methods ................................................................................ 121
Results and Discussion ................................................................................ 128
Literature Cited ............................................................................................ 132
CHAPTER VII: CONCLUSION ............................................................................ 146

viii

LIST OF PREVIOUSLY PUBLISHED PAPERS INCLUDED IN THIS
DISSERTATION
Chapter III published as:
Richeson, J. T., P. A. Beck, M. S. Gadberry, S. A. Gunter, T. W. Hess, D. S. Hubbell, III,
and C. Jones. 2008. Effects of on-arrival versus delayed modified live virus
vaccination on health, performance and serum infectious bovine rhinotracheitis
titers of newly received beef calves. J. Anim. Sci. 86:999-1005.
Chapter IV published as:
Richeson, J. T., E. B. Kegley, M. S. Gadberry, P. A. Beck, J. G. Powell, and C. A. Jones.
2009. Effects of on-arrival versus delayed clostridial or modified live respiratory
vaccinations on health, performance, bovine viral diarrhea virus type i titers, and
stress and immune measures of newly received beef calves. J. Anim. Sci.
87:2409-2418.

ix

CHAPTER I
INTRODUCTION
Bovine respiratory disease (BRD) is a multifaceted syndrome involving
physiological stress, commingling, and several viral and bacterial pathogens. Despite
recent advances in biological and pharmaceutical products designed to prevent and
control the disease, BRD remains the leading cause of feedlot morbidity and mortality
(Woolums et al., 2005) resulting in increased antibiotic usage, reduced animal wellbeing, and decreased growth performance and production efficiency (Holland et al.,
2010). The treatment costs and production losses associated with BRD result in a
significant economic loss to the beef industry (Irsik et al., 2006) estimated to be at least
$750 million annually (Griffin, 1997).
Several factors contribute to the susceptibility and pathogenesis of BRD, one of
the most significant being management and marketing of cattle. As calves move through
the beef production system, stress from handling, weaning, commingling, transport,
environment, and diet transition can combine synergistically resulting in physiological
stress and immunosuppression. Furthermore, the estimated adoption rate of management
factors including weaning (50.2%) or respiratory vaccination (39.4%) in US beef cowcalf operations remains low (USDA, 2010) because logistical challenges exist, cost and
risk are a hindrance, and market availability is limited. The physiological stress and
compromised immune system commonly found in newly received calves may render
initial vaccination incapable of stimulating an effective immune response (Edwards,
2010).
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Commingling from the marketing process can increase exposure to one of the four
viruses known to be associated with BRD: 1) infectious bovine rhinotracheitis, 2) bovine
viral diarrhea virus (BVDV), 3) parainfluenza-3, and 4) bovine respiratory syncytial
virus. Bovine viral diarrhea virus is among the most economically important (Griffin,
1997) of the respiratory viruses, causing severe acute disease (Carman et al., 1998) or
indirect effects of immunosuppression (Welch, 1995). Immunosuppression caused by
acute BVDV infection can allow otherwise commensal bacterial inhabitants of the upper
respiratory tract such as Manheimia haemolytica or Pasteurella multocida, to colonize
the lower respiratory tract and lungs becoming pathogenic. Calves born persistently
infected (PI) with BVDV are a primary transmission source (Houe, 1995); however,
reports on the effects of PI-BVDV exposure on health, production and economic
parameters of feeder cattle are: 1) limited; perhaps due to the challenging logistics of
coordinating these studies, and 2) conflicting; because the management and immune
status of experimental animals may differ and the amount (organisms/mL) and virulence
of the BVDV strain being continually shed by PI challenge animals is varied.
The purpose of this series of experiments was to examine the physiological and
immunological status of newly received calves, determine the effects of on-arrival versus
delayed respiratory vaccination in high-risk, immunosuppressed calves, and observe the
health, performance, humoral and cell-mediated immune response of calves with
different physiological and immunological circumstances and subsequent exposure to PIBVDV challenge.

2

CHAPTER II
REVIEW OF LITERATURE
Overview of Bovine Respiratory Disease in the US
Bovine respiratory disease (BRD) is a multifaceted syndrome involving
physiological stress, commingling, and several viral and bacterial pathogens. Despite
recent advances in biological and pharmaceutical products designed to prevent and
control the disease, BRD remains the leading cause of feedlot morbidity and mortality
(Woolums et al., 2005) resulting in increased antibiotic usage, reduced animal wellbeing, and decreased growth performance and production efficiency (Holland et al.,
2010). Gardner et al. (1999) was among the first studies to demonstrate carcass quality
being negatively impacted by BRD, and more recently Schneider et al. (2009) reported
that in cattle treated for BRD, 16% fewer graded USDA choice than non-treated animals.
Although difficult to assess, the treatment costs and production losses associated with
BRD result in a significant economic loss to the beef industry (Irsik et al., 2006)
estimated to be at least $750 million annually (Griffin, 1997).
Bovine respiratory disease can occur in cattle of all ages and during all beef
production systems; however, the most susceptible animals are physiologically stressed,
immature feeder cattle that are recently weaned from their dam, subjected to
commingling with cattle from other herds, and transported by truck to a stocker or
finishing program where a transition in diet typically occurs. The beef production system
is separated into distinct production segments of cow-calf, stocker, feedlot, packer,
retailer, and ultimately, the beef consumer. Ownership frequently changes with each
segment; therefore, an informational disconnect exists regarding the performance,
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efficiency and health of calves as they move from one segment to another. This
fundamental segmentation of the beef production system increases the susceptibility to
BRD in the beef industry because inherent stressors exist as calves progress from one
production segment to another. With the traditional auction market system, sellers convey
health risk of their calves to the buyer with little consequence because communication
among buyer and seller is rare. Another marketing roadblock for mitigation of BRD is the
limited value-added marketing opportunities available to small cow-calf producers that
wish to invest labor and resources in vaccination and management practices that can
greatly reduce BRD health risk. Furthermore, because the estimated average herd size in
the US is small (average = 42.9; USDA, 2007), a logistical challenge exists. Most cowcalf producers do not annually produce enough calves needed to comprise a full truckload lot of ~22,500 kg (i.e. 90 calves weighing 250 kg), which limits options for directmarketing or retained-ownership. Therefore, the commodity-based auction market system
is the most common method of feeder cattle sale in the US (USDA, 2010), and most
calves are sold individually (Troxel et al., 2002). Selling feeder cattle individually
contributes to commingling because cattle buyers must assemble a full truck-load lot with
cattle from multiple cow-calf operations, and commingling results in increased stress and
BRD morbidity (Step et al., 2008) because the social hierarchy of a group must be reestablished and exposure to novel pathogens is more likely.
The BRD mortality rate in US feedlots has remained relatively unchanged over
the past 3 decades (Miles, 2009). One cause of the feedlot mortality rate remaining
unchanged despite significant improvements in vaccine efficacy and antimicrobial
availability may be the low adoption rate by beef producers of preconditioning
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management practices that reduce physiological stress and improve disease resistance.
According to the USDA Beef 2007-08 survey of US cow-calf producers, the estimated
adoption rate of several cow-calf health management factors including castration
(49.5%), weaning (50.2%), and respiratory vaccination (39.4%) remains low (USDA,
2008; USDA, 2010) and increases in the adoption rate of these management practices
were not observed from the previous decade (Beef ’97; USDA, 1997).
The pathogenesis of BRD typically occurs in a distinctive step-wise manner.
Initially, stress from weaning, marketing, and transport of feeder cattle results in
immunosuppression during a time of extensive commingling when potential viral
pathogen exposure is increased, and naïve, immunosuppressed calves are more
susceptible to viral pathogens associated with BRD. The 4 primary viral pathogens
associated with BRD include: 1) bovine herpesvirus-1 (also known as infectious bovine
rhinotracheitis virus; IBRV), 2) bovine viral diarrhea virus (BVDV), 3) parainfluenza3
virus (PI3V), and 4) bovine respiratory syncytial virus (BRSV). Immunosuppression
resulting from concurrent management stress and viral infection in calves allow
otherwise commensal bacteria inhabiting the respiratory tract to defeat a compromised
immune response and proliferate extensively in the nasopharnyx and bovine lung
resulting in “shipping fever” pneumonia (Hodgson et al., 2005). Furthermore, coinfection of viral and bacterial respiratory pathogens results in viral-bacterial synergy
(Ohmann and Babiuk, 1985). As many as 5 different bacterial species, both Gramnegative and Gram-positive, are described today in their involvement of BRD. The most
common bacterial pathogen associated with BRD is Manheimia haemolytica serotype 1
(Pandher et al., 1998); however, Pasteurella multocida, and Haemophilus somnus are less
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frequently isolated. The unique virulence factors of each bacterium, combined with the
host immune response can cause significant inflammation resulting in moderate to severe
lung damage, morbidity or mortality of the host.
Vaccination with an efficacious, multivalent respiratory vaccine containing
antigen strains of IBRV, PI3V, BVDV, and BRSV can be highly effective at preventing
BRD if administered to an immunocompetent animal (Perino, 1996). However, the
efficacy of on-arrival vaccination in high-risk, newly received calves is questionable
(Perino and Hunsaker, 1997) because these calves may have been previously exposed to
viral pathogens during the marketing process and disease progression may be at a period
where vaccination is unable to provide protection.
Effects of Physiological Stress on Stocker and Feedlot Cattle
Overview and Potential Biomarkers of Stress and Disease
The concept of stress can be traced to Empedocles, a Greek philosopher during
the fifth century B.C. In the late 1930s, an endocrinologist named Hans Selye is credited
as the first person to use the term stress as it pertains to modern understanding. Selye
defined stress as “the body’s nonspecific response to a demand placed on it”. In general,
stress is any external or internal challenge that disrupts the internal environment
(Sheridan et al., 1994). As our understanding of physiological stress has improved, its
role in growth regulation, immunosuppression and disease susceptibility has as well.
The most significant impact of stress is the negative effect it has on feed intake
and immunocompetency (Loerch and Fluharty, 1999), both of which may have a direct
role in the development of BRD. Loerch and Fluharty (1999) identified 5 consequences
when stressors are manifested in cattle: 1) transient endocrine responses are likely, 2)
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products of energy and protein metabolism may be altered, 3) appetite and growth rate
are affected, 4) digestion and rumen function may be compromised, and 5) an animal’s
immune system may be challenged. Furthermore, a review by Grandin (1997) postulated
2 broad categories of stress in cattle: 1) psychological stress caused by commingling,
handling or fear, and 2) physical stress caused by hunger, disease or injury.
Stress stimuli associated with either category can result in physiological alteration
by activating the hypothalamic-pituitary adrenal axis leading to increased serum or
plasma levels of glucocorticoids. Glucocorticoids such as cortisol have been linked to
immunosuppression (Roth, 1985) and thus, the potential for increased disease
susceptibility in cattle. However, changes in cortisol concentrations in response to
different stress stimuli commonly encountered during the beef production system are
varied. Several studies report stress-induced increases in cortisol concentrations of cattle
(Kegley et al., 1997; Tyler and Cummins, 2003; Gupta et al., 2005), and Anglen et al.
(2003) observed animals that underwent restraint stress failed to mount a normal immune
response, which resulted in increased susceptibility to a subsequent pathogen challenge.
Crookshank et al. (1979) reported that corticosteroids were most responsive to transport
stress; however, other trials reported no differences in cortisol concentration when
subjected to weaning (Lefcourt and Elsasser, 1995) or transport (Galyean et al., 1981)
stress.
More recently, products of the pro-inflammatory response have been identified as
potential biomarkers that may respond to host stress or immune challenge. Acute phase
proteins (APP) such as haptoglobin, fibrinogen, ceruloplasmin, or serum amyloid-A are
produced and secreted by the liver and have been measured in the blood of animals
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subjected to transport, commingling or weaning stress because the rate of synthesis of
APP can increase several hundredfold when influenced by pro-inflammatory cytokines
(Klasing and Korver, 1997). Arthington et al. (2003) investigated the effect of
transportation and commingling on measures of the APP response of newly weaned beef
calves and reported that transported calves had greater serum amyloid-A, fibrinogen, and
ceruloplasmin concentrations, yet significantly lower haptoglobin concentrations than
non-transported controls. Haptoglobin levels may also correlate with clinical respiratory
disease; Wittum et al. (1996) reported that feedlot calves treated for BRD had decreased
serum haptoglobin concentrations from initial to final examination compared to calves
never receiving antibiotic treatment. Although these APP are commonly used as
biomarkers to determine the incidence of stress in cattle, their effects on disease
pathology is less clear.
Interferon-γ is involved in innate immunity serving as a macrophage-activating
cytokine when it is released by natural killer cells responding to infected or stressed host
cells, and adaptive immunity when released by T-cells subsequent to antigen recognition
(Abbas, 2007). Interferon-γ levels are responsive to stressors such as castration (Fisher et
al., 1997), weaning (Hickey et al., 2003), and endotoxin challenge (Carroll et al., 2009;
Kahl and Elsasser, 2006).
Another biomarker for stress and disease is total and differential leukocyte cell
concentrations of blood. These cells of the immune system include neutrophils,
lymphocytes, monocytes, eosinophils, and basophils that each comprise a unique role in
innate and adaptive immunity. Increases in the concentration of these cell types is
indicated with the suffix “philia” (i.e. neutrophilia), and is generally attributed to
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inflammation and immune stimulation (Merck, 1998). Conversely, decreases are
indicated by the suffix “penia” (i.e. neutropenia) and this condition is often associated
with endogenous stress because resulting corticosteroids and pro-inflammatory cytokines
mediate lysis of leukocytes. Although perhaps less extensively researched in the bovine
model, an increased neutrophil:lymphocyte (N:L) ratio is implicated as an indication of
shipping stress in pigs (McGlone et al., 1993) and social stress in chicks (Gross and
Siegel, 1983).
Interaction of Stress and Immunity
Produced primarily by LPS-stimulated macrophages and T-cells, TNF-α mediates
inflammation and recruitment of immune cells to areas of infection, especially during
endotoxin infection; thus TNF-α regulates components of both innate and adaptive
immunity. Carroll et al. (2009) observed that both TNF-α and IL-6 concentrations
increased following endotoxin challenge in calves, and the magnitude of increase was
greater for calves weaned at 250 d of age versus early-weaned at 80 d of age and shipped
to a receiving facility.
In a review of stress and immunity in swine and cattle, Salak-Johnson and
McGlone (2007) proposed that hormonal and immunological products influenced by
physiological stress such as cortisol, IFN-γ, and IL-4, modulate T helper cell
differentiation, thereby influencing the direction of the immune response (i.e. humoral vs.
cell-mediated). Activated CD4+ T lymphocytes differentiate into distinct subsets called T
helper1 (Th1) and T helper2 (Th2) cells during priming of immature CD4+ T
lymphocytes, and IFN-γ and IL-4 influence the differentiation process (Mosmann and
Coffman, 1989). If a T lymphocyte differentiates into a Th1 effector cell, these cells both
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secrete and are regulated by IFN-γ, which activate CD8+ cytotoxic T cells (cell-mediated
immunity); whereas, Th2 effector cells activate B cells to produce antibodies (humoral
immunity) and are regulated by and secrete IL-4, which inhibits Th1 (Coffman, 2006).
Furthermore, glucocorticoids inhibit many pro-inflammatory cytokines and may favor a
Th2 or humoral immune response (Wiegers et al., 2005). Salak-Johnson and McGlone et
al. (2007) concluded that stress may shift the balance between Th1 and Th2 immune
response, and the conflicting reports of stress and immune interactions in animals may be
partially explained by the type and duration of stressor, age, genetics, and social status of
experimental animals used within and among studies.
Filion et al. (1984) investigated the role of stress in the induction of pneumonic
pasteurellosis of calves challenged with respiratory virus (IBR) or bacteria (Pastuerella
haemolytica). Calves subjected to weaning, transportation, and handling in a feedlot were
more susceptible to IBR, but not Pastuerella haemolytica challenge. Nevertheless,
interactions of stress and viral-bacterial synergy in BRD have been described by Hodgson
et al. (2005). In their review, 2 unique mechanisms by which stress-induced
corticosteroids may directly and indirectly modulate viral-bacterial synergy which
contributes to BRD were identified. First, corticosteroids may directly inhibit the proinflammatory responses induced by increased toll-like receptor expression through
inhibition of transcriptional regulators NFκB and AP-1. Additionally, corticosteroids may
indirectly regulate the pro-inflammatory response because of their effects on T cell
development and increased IL-10, an anti-inflammatory cytokine. The authors concluded
that stress has a significant impact on prevalence and severity of respiratory disease in
human and animal models.
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Babiuk et al. (1987) treated newly received calves intranasally or intramuscularly
with recombinant bovine interferon-α, an immunomodulator and inhibitor of viral
replication, 48 h prior to challenge with IBR, followed 4 d later with Pastuerella
haemolytica challenge. In this study, interferon-α administration greatly reduced clinical
BRD, mortality, weight loss, and mean lung score indicated by pneumonic lesions upon
necropsy. Furthermore, evidence of bacterial-viral synergy existed for control treatments
not receiving interferon-α; these animals exhibited increased clinical illness score and
temperature following d 0 IBR challenge, and these indices were further increased
immediately following Pastuerella haemolytica challenge on d 4.
The modulation of humoral and cell-mediated immune response resulting from
stress-induced physiological alterations, and the impact on vaccine response and disease
outcome in newly received beef cattle warrants further investigation.
Interaction of Stress and Growth
Stimulation of the immune system can also be considered a stressor and research
indicates the immune response to endotoxin challenge can cause a metabolic shift to
repartition nutrients away from tissue deposition in favor of immunity (Elsasser et al.,
1995). Several pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α),
interferon-γ (IFN-γ), and interleukin-6 (IL-6) have been shown to be responsive to stress
stimuli and are critical products of the immune response during an infectious challenge,
yet can impair growth either directly by acting on tissues or indirectly through their
effects on the endocrine system (Klasing and Korver, 1997).
Moreover, growth hormone (GH) and insulin-like growth factor-I (IGF-I) are
critical in regulating growth and tissue deposition (Spurlock, 1997), and these hormones
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are inversely altered during endotoxin challenge. An endotoxin challenge study using a
mouse model reported decreased levels of plasma GH returning to baseline within 24 h;
however, IGF-I remained low at 24 h (Fan et al., 1995). Therefore, because blood
concentrations of TNF-α are elevated during endotoxin challenge, this would suggest
increased TNF-α levels being correlated with decreased GH and IGF-I. Johnson (1997)
reviewed pro-inflammatory cytokine regulation of growth and proposed that anorectic
and metabolic effects of immunological challenge occur because: 1) several bacterial and
viral pathogens stimulate leukocytes to synthesize and secrete cytokines, 2) animals with
either clinical or subclinical infections are anorectic, 3) exogenous inflammatory stimuli
and recombinant cytokines, when injected into animals, have anorectic and metabolic
properties that characterize immunological stress, 4) bona fide receptors for cytokines are
present in disparate nonimmune tissues, and 5) the anorectic properties of IL-1 are
blocked by a specific receptor antagonist.
Klasing and Korver (1997) reviewed the effects of leukocytic cytokine immune
stimulation by both pathogens and experimentally-induced cytokine levels on growth
rate, feed intake, and feed efficiency. The authors refer to direct evidence of proinflammatory cytokines as mediators of growth in experiments which closely duplicate
the qualitative and quantitative aspects of cytokine release in vivo (Klasing et al., 1987).
In this series of experiments (Klasing et al., 1987), cortisol and IL-1 concentrations in
immunologically challenged chicks were greater than in non-challenged controls.
Furthermore, to determine the influence of cortisol and IL-1 on protein degradation and
synthesis, skeletal muscles were incubated in the presence of cortisol and IL-1 at
concentrations similar to those seen after immune challenge. It was observed that cortisol
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did not affect the rate of protein degradation; however, rate of protein synthesis was
reduced compared to control. Conversely, IL-1 did not affect rate of protein synthesis but
resulted in a 24% increase in protein degradation compared to control. In addition to
modulation of protein synthesis and degradation, cytokines can impair growth through
induction of anorexia (Plata-Salaman, 1996) and Yang et al. (1994) observed synergistic
effects of TNF-α and IL-1 in inducing anorexia in rats. Direct and indirect effects of proinflammatory cytokines may decrease feed intake by more than 50% during acute disease
challenge (Klasing and Korver, 1997).
Identified Stressors in Beef Cattle Management
Weaning
Weaning is one of the most stressful events encountered in beef calves. Weaning
can be described two-fold: 1) to accustom a young animal to take nourishment other than
by suckling, and 2) to detach from that to which one is strongly habituated or devoted. As
calves mature they transition from a diet consisting primarily of milk, to a diet consisting
of forage, grain, or both. Although necessary to facilitate standard beef production
practices, weaning results in psychological (Price et al., 2003) and physiological (Hickey
et al., 2003) stress, and recently weaned, newly received calves must learn to consume
feed and water from a bunk or trough. Hickey et al. (2003) evaluated N:L ratio, plasma
cortisol and APP concentration and IFN-γ production in abruptly weaned calves. The N:L
ratio was increased and IFN- γ response to an antigen, keyhole limpet haemocyanin, was
reduced for weaned calves versus control; however, no differences were observed for
cortisol, haptoglobin, or fibrinogen in this experiment. Arthington et al. (2008) evaluated
measures of stress and performance in 96 steers over a 2-year period in 4 weaning
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management treatments: 1) control: weaned on the day of shipment, 2) creep-fed:
allowed free-choice access to concentrate before weaning and shipment, 3) preweaned:
weaned and provided supplemental concentrate on pasture before shipment, and 4) earlyweaned: weaned at 70 to 90 d of age and kept on pasture. Overall ADG was greater for
early-weaned vs. control steers during the 29-d receiving period. Before shipment (d 0),
plasma ceruloplasmin concentration was less for control vs. early-weaned steers;
however, subsequent to shipment on d 15 and 22, ceruloplasmin was greater for control
vs. early-weaned steers. Plasma haptoglobin concentrations tended to be greater for
creep-fed vs. preweaned calves, but no other differences in haptoglobin concentrations
were observed. In a subsequent experiment (Carroll et al., 2009), a more intensive
investigation into the immunological response of early-weaned (80 d of age) vs. normalweaned (250 d of age) calves was conducted after endotoxin challenge. Serum samples
were analyzed for TNF-α, IFN-γ, IL-1β, IL-6, cortisol, ceruloplasmin, and haptoglobin. A
weaning × time interaction was observed for TNF-α, IL-1β, IL-6, and ceruloplasmin;
these indices were greater for normal-weaned vs. early-weaned calves subsequent to
endotoxin challenge. Furthermore, a weaning effect was reported for haptoglobin, with
serum concentrations being greater for normal-weaned. The authors concluded that the
immune system of early-weaned calves appears to be more competent in responding to
pathogen challenge than normal-weaned calves.
Transportation
Transportation of cattle by truck to and from the different cow-calf, stocker, and
feedlot segments is yet another inherent stressor associated with the beef production
system. Blecha et al. (1984) performed research on the effects of transportation stress and
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the immune response in which steers were either shipped 700 km to a feedlot or remained
at the origin ranch. Transported steers had greater total leukocytes and neutrophils;
however, cortisol concentrations did not differ. Lymphocyte blastogenic responses were
reduced after transport; whereas, monocyte phagocytosis and packed cell volume were
not affected by transportation. Evidence also suggests that confinement associated with
the transportation process may play a significant role in transit stress. Phillips (1984)
observed increased concentrations of fibrinogen when steers were shipped 400 km and
confined in novel surroundings for 15 h, yet this increase was not different from steers
that were confined without transport. Buckham Sporer et al. (2008) observed several
alterations in physiological blood parameters following a 9-h truck transportation of beef
bulls. Blood was collected at -24, 0, 4.5, 9.75, 14.25, 24 and 48 h from initiation of
transport (0 h). Plasma concentrations of haptoglobin and fibrinogen were decreased with
the onset of transportation stress. Conversely, plasma cortisol increased sharply by 4.5
and 9.75 h after transport, returning to sub-baseline at 14.25 h. Furthermore, total
leukocytes increased in response to transportation stress. Although effects on these
measurements beyond 48-h were unknown, rapid, acute physiological changes were
clearly evident and garner potential as biomarkers for stress and disease. Stanger et al.
(2005) performed a similar transportation stress study; however, blood collection
occurred 48 h before transport, immediately following a 72 h transport event, and 6 d
thereafter (216 h). In this study, IFN-γ production did not differ; whereas, total leukocyte
concentration following transport decreased transiently at 72 h and returned to near
baseline values by 216 h. To determine effects of weaning and transportation on APP
response, Qiu et al. (2007) evaluated blood APP concentrations periodically in 3 breeds
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of cattle. Blood samples were collected at weaning and at 24 and 72 h after weaning.
Additionally, blood was collected immediately before shipment, upon arrival, and 24 and
72 h after arrival. Haptoglobin and fibrinogen concentrations were significantly increased
at 72, but not 24 h after weaning. In response to transportation stress, haptoglobin
concentrations were least prior to shipment, intermediate for on-arrival and 72 h after
shipment, and greatest 24 h after shipment. Fibrinogen was increased on-arrival and 72 h
post-shipment, but not 24 h after shipment, compared to pre-shipment fibrinogen
concentrations.
Castration
Castration is necessary to reduce aggressive and sexual behavior and improve
meat quality in male cattle, yet the practice causes pain and stress that temporarily
reduces performance (Fisher et al., 1996), and the performance reduction due to
castration is greater in older bulls that are also experiencing weaning stress (Peterson et
al., 1989). Bretschneider (2005) reported that castration closer to birth resulted in less
weight loss for the 30-day period following castration. The immune status may also be
altered by castration, as evidenced by increased leukocytes in the blood for castrates vs.
controls (Chase et al., 1995), and the incidence of BRD has been reported to be much
greater in calves castrated on arrival at a feedlot (Daniels et al., 2000).
Fisher et al. (1997) determined the effects of castration on cortisol concentration,
in vitro IFN-γ production, leukocyte concentration, and plasma haptoglobin and
fibrinogen concentrations. On d 1, surgically castrated animals had lower IFN-γ
production and greater neutrophil and N:L ratio compared to control. Plasma haptoglobin
on d 1 and 3 and fibrinogen concentrations on d 3 and 7 were increased for castrated
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animals. Growth performance was also affected by castration; ADG was less for the first
7 d in surgically castrated animals. Their results indicate significant physiological
alterations in response to surgical castration; whereas, performance was transiently
reduced in castrated animals.
Commingling
A less investigated area of management research is the effect of commingling
cattle on health and performance. To mitigate the effects of commingling and marketing
stress, single-source cattle are purchased from larger cow-calf ranches through directmarketing; however, commingling is inherent in the auction market process because
cattle from small cow-calf farms are often sold one at a time, and an order buyer
purchasing cattle for a stocker of feedlot operation must assemble larger group lots
weighing ~22,727 kg to facilitate a full truckload. The commingling of cattle results in 2
primary issues: 1) potential exposure to un-encountered pathogens increases, and 2) the
hierarchy of the newly assembled group must be established resulting in increased
psychological and physiological stress. Because commingling during the marketing
process both increases the potential of viral pathogen exposure and increases stress, acute
infection with respiratory viruses is more likely because stress-induced
immunosuppression allows viruses to evade host immune defense mechanisms (Sheridan
et al., 1994). Step et al. (2008) evaluated effects of health and performance in beef calves
from a single-source ranch (RANCH) either weaned and immediately shipped to a feedlot
(WEAN), weaned and kept on the ranch for 45 d before shipment without receiving any
vaccinations (WEAN45), weaned and kept on the ranch for 45 d before shipment and
vaccinated with a MLV respiratory vaccine (WEANVAC45), procured and assembled
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through several auction markets (MARKET), or a commingled group (COMM)
containing a portion of RANCH and MARKET origin cattle. Regardless of weaning or
vaccination status, calves originating from RANCH tended to have greater ADG than
COMM or MARKET calves for the 42-d receiving period. Clinical morbidity was
greatest for MARKET, intermediate for COMM, and least for RANCH. Gupta et al.
(2005) observed increased plasma cortisol, albumin, urea, and nonesterified fatty acids in
14 mo-old Holstein-Friesian steers that were subjected to repeated regrouping and
repenning. Arthington et al. (2003) observed effects of transport and commingling in
newly weaned calves on plasma fibrinogen, ceruloplasmin, haptoglobin, and cortisol
concentrations. No differences were observed for commingling in this study; however,
commingling was not extensive, consisting of 2 outsourced steer calves being placed in
the commingled-designated pens. Transportation effects were reported for fibrinogen in
experiment 1 and haptoglobin in experiment 2; both of these APP increased after
transport.
Effects of Preconditioning Management on Bovine Respiratory Disease and Growth
Performance
Preconditioning is a comprehensive management practice first identified in the
1960s designed to reduce the incidence and susceptibility to BRD during the stocker and
finishing segments of the beef production system. The negative effects of stress are
mitigated through preconditioning management; however, this must occur during a
critical time period before marketing and transport to a stocker operation or feedlot
occurs. Although the specific requirements of different preconditioning programs may
vary, typical requirements include weaning calves on their origin ranch for a specified
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time (i.e. ≥ 45 d), vaccinating against clostridial (Clostridium chauvoei-septicum-novyisordellii perfringens type C & D) and respiratory (IBR, BVDV type 1 & 2, PI3V,
BRSV) antigens, treatment with anthelmintic, castration, dehorning, and training to
consume feed from a bunk and water from a trough before being marketed or transported
to a stocker or feedlot facility (Cole, 1985; Duff and Galyean, 2007). Each of these
preconditioning requirements functions to reduce stress and disease risk in preparation
for the stocker or feedlot environment. For example, in the preconditioned calf, weaning
stress is reduced and overcome on the ranch of origin before shipping and commingling
occurs. This mitigates the additive effect of multiple stressors by shifting stress
occurrences earlier (ie. weaning stress on the ranch of origin rather than during transport
to a feedlot with concurrent stressors). Justifiably so, preconditioned cattle are more
valuable than non-preconditioned cohorts. Net return for preconditioned vs. nonpreconditioned steers selling in a Kansas auction market from 1999 to 2004 was
estimated between $14.28 (winter) and $31.84 (fall)/animal depending on market
conditions, calf weight and condition (Dhuyvetter et al., 2005). Whereas, the estimated
$40 to $60/animal value of preconditioned cattle in the feedlot is considerably greater
than the estimated net return from marketing preconditioned calves (Dhuyvetter et al.,
2005).
Although research is surprisingly limited, several studies demonstrate that
preconditioning management reduces the incidence of BRD and increases gain
performance. In a trial conducted by Clark et al. (2006), crossbred beef steers of low(preconditioned) or high-risk for BRD were used to evaluate differences in health and
performance. Preconditioned calves had greater average daily gain (ADG) during the
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finishing period than high-risk auction market calves of unknown history; however, no
differences in performance were observed during the 28-d receiving period. Antibiotic
treatment cost was also reduced, averaging $15.55 and $0.26/steer for high- and low-risk
cattle groups, respectively. Seeger et al. (2008) observed that auction market steers of
unknown origin or health history gained 0.18 kg/d less during a finishing period than
weaned beef calves receiving a health protocol on their origin ranch prior to marketing;
however, an unequal number of calves testing positive for PI-BVDV remained in their
treatment pens during the trial which may have confounded results. Another study
(Macartney et al., 2003) reported that calves of unknown health history had greater
morbidity compared with those administered health protocols prior to marketing.
Furthermore, Roeber et al. (2001) observed that cattle originating from preconditioning
programs had fewer hospital visits than cattle originating from auction markets. Earlier
research conducted by Pritchard and Mendez (1990) suggested that non-preconditioned
calves may fully compensate for initial performance loss by the end of the feeding period;
however, the non-preconditioned cattle used in that experiment would be considered lowrisk by current industry accepted standards because they were maintained as a singlesource and were not subjected to stressors associated with the auction market system.
Overview of Bovine Viral Diarrhea Virus and its role in Bovine Respiratory Disease
Bovine viral diarrhea virus is a critical viral pathogen that can adversely affect
reproduction, performance and health of beef cattle from the point of conception through
the finishing phase of the beef cattle industry. A member of the pestivirus genus within
the Flavivirus family (Ridpath, 2008), BVDV is classified into genetically distinct
genotype groups 1 and 2, and is further classified into subgenotypes 1a, 1b, 2a, and 2b
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(Ridpath, 2005), among others. In addition to genetic differentiation, the biotype of a
specific BVDV strain is classified as cytopathic or noncytopathic based upon its ability to
cause cellular damage in cultured cells (Peterhans et al., 2010). Research would also
indicate that antigenic differences may exist among BVDV subgenotypes because
differences in cross-neutralization are observed (Bachofen et al., 2008). Furthermore,
Burciaga-Robles et al. (2010) observed increased antibody titers to BVDV subgenotype
1b (strain TGAC 8HB), but not type 1a (Singer strain) or 2a (strain 125-C) when steers
were exposed to 2 PI-BVDV type 1b challenge animals for 72 h. Ridpath et al. (2010)
reported that the ratio of virus cross-neutralization among BVDV type 1a and 1b
subgenotype strains is 36%. These findings identify a critical need for further research
because currently no commercially licensed modified-live virus (MLV) respiratory
vaccine in the US contains a BVDV type 1b isolate. Also noteworthy, BVDV type 1b is
the predominant strain isolated from calves in the US with respiratory disease (Fulton et
al., 2002).
Bovine viral diarrhea virus infection of susceptible cows during the second to
fourth month of gestation (Peterhans et al., 2010) can result in the birth of a persistently
infected (PI), immunotolerant calf (McClurkin et al., 1984) that will shed large amounts
of the noncytopathic biotype of the BVDV subgenotype strain it was exposed to in utero
throughout its entire lifetime (Kahrs, 2001). There may be a correlation between the
majority of PI-BVDV calves being infected with BVDV subgenotype 1b (Fulton et al.,
2005), and the fact that this specific BVDV strain is not included in commercial vaccines
that could provide protection against BVDV emergence in the field. Nevertheless, PIBVDV calves may contribute to one of the most critical consequences of BVDV
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infection, BRD complex, by acting as a primary respiratory pathogen source or through
immunosuppression of exposed cohorts (Welsh et al., 1995). Although the prevalence of
PI-BVDV calves in the feedlot is estimated to be relatively low (0.3%; Loneragan et al.,
2005), a single PI-BVDV animal has the potential to continuously expose an entire pen
and adjoining pens to the virus. Moreover, the large population of confined cattle that
exist for a typical commercial feedlot located in the high-plains region of the US suggests
that more than 100 PI-BVDV animals may be sporadically located throughout a single
facility (ie. 50,000 animals × 0.3 prevalence rate = 150 PI-BVDV animals).
Some consultants and veterinarians have promoted to stocker or feedlot clientele
with limited success, testing upon arrival and removal of animals identified as PI-BVDV.
A significant barrier to more widespread adoption of this practice is the conflicting
research on effects of PI-BVDV exposure reported in the literature. Nevertheless, several
commercial and university veterinary diagnostic laboratories offer PI-BVDV testing
services. The latest, most efficient procedure to determine PI-BVDV status is to test an
ear-notch tissue sample for the presence of BVDV using the antigen-capture, or
competitive enzyme-linked immunosorbent assay (ACE) via a commercially available
test kit (IDEXX HerdChek, IDEXX Laboratories, Westbrook, ME). At the present time,
the commercial laboratory fee to perform an ACE test ranges from $3.75 to $5.00 per
sample excluding next day parcel service fees. Because PI-BVDV calves often appear
otherwise healthy with no visual symptoms of disease, it is impossible to visually identify
and remove suspected PI-BVDV animals; therefore, a stocker or feedlot producer
considering this management practice must test an entire population of newly received
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calves to identify and remove PI calves, representing a significant cost to a producer
considering this management strategy.
Research results on effects of exposure to PI-BVDV calves in the feedlot are both
limited and conflicting; thus, the decision to invest in PI-BVDV testing and removal of
PI-positive animals to minimize economic losses associated with BVDV exposure of
newly received cattle remains controversial. Elam et al. (2008) evaluated the effects of
long- (duration of study) or short-term (60 h) exposure to a calf identified as PI-BVDV in
heifers that had been previously vaccinated for BVDV and received antibiotic
metaphyalxis upon arrival. In this study, no differences in final body weight, dry matter
intake, feed efficiency, or carcass characteristics were observed with PI-BVDV exposure.
Furthermore, none of the experimental animals in this study required treatment for BRD,
indicating that PI-BVDV exposure did not affect BRD morbidity; however, based upon
the excellent health of experimental animals, physiological stress and
immunosuppression was probably minimal for heifers in this study. Booker et al. (2008)
performed a prospective study in 3 Alberta feedlots to observe differences in health and
performance outcomes of pens with or without a PI-BVDV calf present. Although
mortality attributed to BVDV was more common in pens containing a PI-BVDV animal,
no differences in morbidity, overall mortality, ADG, or feed efficiency were observed
between PI and non-PI pens. Both Elam et al. (2008) and Booker et al. (2008) concluded
that the presence of a PI-BVDV calf had little or no effect on health or performance, and
both authors suggested that PI-BVDV exposure may provide enhanced immunity against
acute BVDV infection.
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Loneragan et al. (2005) conducted a cross-sectional study to estimate prevalence
of PI-BVDV cattle in the feedlot population, prevalence of chronically ill and dead PIBVDV cattle, and the effects on BRD morbidity when exposed to a PI-BVDV calf.
Prevalence of PI-BVDV cattle arriving in the feedlot was 0.3%, and it was reported that
cattle exposed to a PI-BVDV animal had a 43% greater risk of developing BRD.
Furthermore, a greater percentage of PI-BVDV animals were present in chronically ill
(2.6%) and dead (2.5%) cattle. In a study evaluating the effects of PI-BVDV exposure of
high-risk auction market calves of unknown history (Hessman et al., 2009), cattle directly
exposed to PI-BVDV challenge had a greater percentage of first relapse, chronic illness,
and fatalities; however, overall morbidity was not different compared to unexposed
groups. It was determined through economic analysis that fatalities and performance
losses due to PI-BVDV exposure accounted for economic losses of $5.26 and
$88.26/animal, respectively. Furthermore, the authors provided comprehensive
discussion on susceptibility of PI-BVDV exposure attributing factors of virulence and
amount of virus particles being shed, frequency of contact, population density, and
immunocompetence of exposed cohorts as factors that can affect the magnitude of health
and performance outcome in studies evaluating PI-BVDV exposure.
O’Conner et al. (2005) evaluated the association between commingling and PIBVDV exposure on feedlot pen morbidity. They reported that disease prevalence was
least in pens containing single-source cattle with a PI-BVDV calf present, and exposure
to PI-BVDV in commingled groups also reduced morbidity compared to commingled
pens with no PI-BVDV calf. Nevertheless, commingling was associated with an increase
in BRD morbidity. Fulton et al. (2006) suggested that calves previously vaccinated and

24

preconditioned prior to exposure to a PI-BVDV animal can provide protection against
viremia compared to naïve calves. One inconsistency among PI-BVDV research is the
use of experimental cattle with varied management and vaccination history, and peerreviewed research evaluating effects of PI-BVDV exposure in different BRD risk-groups
of cattle such as single source, preconditioned versus commingled, auction market calves
is lacking.
Research on the effects of PI-BVDV exposure on APP and cytokine response is
limited. Burciaga-Robles et al. (2010) examined effects of an intratracheal Manheimia
haemolytica challenge after 72-h exposure to PI-BVDV subgenotype 1b calves on
leukocyte and cytokine concentration of feedlot steers. Steers were randomly allocated to
1 of 4 treatments in a 2 × 2 factorial arrangement: 1) not exposed to PI-BVDV challenge
nor challenged with M. haemolytica (control), 2) exposed to PI-BVDV challenge for 72
h, 3) intratracheally challenged with M. haemolytica, and 4) exposed to PI-BVDV
challenge for 72 h and challenged with M. haemolytica. A main effect of PI-BVDV
exposure was observed, with PI exposure resulting in reduced numbers of total
leukocytes, neutrophils, lymphocytes, eosinophils, and basophils. Haptoglobin
concentrations were not different in steers exposed to PI-BVDV challenge; conversely,
Ganheim et al. (2003) reported greater haptoglobin concentrations in steers challenged
intranasally with BVDV type 1. Several pro-inflammatory cytokine levels were impacted
in the Burciaga-Robles et al. (2010) study. Exposure to PI-BVDV challenge resulted in
increased IL-1, IL-6, and TNF-α concentrations; whereas, tendencies were noted for IFNγ and IL-4. A treatment interaction was observed for IFN-γ, with concentrations being
greatest for steers exposed to both BVDV and M. haemolytica challenge models, and
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least for control, BVDV only, and M. haemolytica only challenge. A similar treatment
interaction was observed for TNF-α, with the greatest serum concentration observed for
calves exposed to both disease challenge models, suggesting that exposure of naïve
calves to PI-BVDV challenge increased the potential for secondary infection.
Conclusions from the Literature
Implementation of management (or lack thereof) through the unique segments of
the beef production system can tremendously impact the health, growth performance, and
profitability of feeder cattle. As the scientific literature evolves regarding interactions of
management, physiological stress, and immunosuppression, hopefully adoption of
management and discovery of new products or methods for mitigation of bovine
respiratory disease will increase, thereby reducing the industry’s dependence on
antibiotics to treat bovine respiratory disease. Several biomarkers that may indicate
physiological stress and disease status, and the continually improving assays to detect
such biomarkers, hold promise for future research and understanding. Improved
understanding of physiological stress and its resulting modulation of immunity and
disease will have profound effects on the health and well-being of cattle, profitability,
and ultimately sustainability of the beef industry.
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ABSTRACT: Stress commonly associated with weaning, marketing, and shipment of
feeder cattle can temporarily compromise immune function; thereby, reducing the
effective response to vaccination intended to control bovine respiratory disease (BRD).
Two vaccination timing treatments were used to evaluate the effect of timing of a
multivalent modified live virus (MLV) BRD vaccine on health, performance, and
infectious bovine rhinotracheitis (IBR) antibody titer level of newly received stocker
cattle. Crossbred bull and steer calves (n = 528) were weighed (197 ± 2.4 kg) and
randomly assigned to MLV vaccination treatment: 1) MLV vaccination upon arrival
(AMLV), or 2) delayed (14 d) MLV vaccination (DMLV). All cattle were processed
similarly according to routine procedures with the exception of initial MLV vaccination
timing. Subsequently, BW were recorded on d 14, 28, and 42. Blood samples were
collected on d 0, 14, 28, and 42 to determine differences in serum IBR titer levels, and
comparisons were made between treatments on a receiving-day basis and an equivalent
postvaccination day basis. Daily BW gains were greater (P ≤ 0.05) for DMLV calves
from d 0 to 14 (1.16 vs. 0.88 ± 0.22 kg/d) and from d 0 to 42 (0.75 vs. 0.65 ± 0.09 kg/d).
Days to first treatment, total treatment cost, percentage death loss, and pasture ADG after
the 42-d receiving period did not differ (P ≥ 0.15). Morbidity rates for BRD were high for
both AMLV and DMLV (71.5 and 63.5%, respectively), and did not differ (P = 0.12).
Positive IBR titer seroconversion was greater (P ≤ 0.03) for DMLV calves on d 42 of the
study, and for the 28- and 42-d equivalent postvaccination basis. Delaying vaccination by
14 d may increase ADG during the receiving period compared with AMLV and
seroconversion to IBR was greater in DMLV calves, indicating a possible improvement
in acquired immune response when MLV vaccination is delayed.
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INTRODUCTION
Bovine respiratory disease (BRD) is the most economically important disease in
newly received beef cattle (Edwards, 1996), and is the leading cause of morbidity and
mortality according to a recent survey of US feedlots (Woolums et al., 2005). A common
receiving management strategy includes classification of cattle groups into risk categories
(high or low risk) for BRD; this is determined by factors including transportation stress,
immune status, nutritional condition, environment, and the skill level of management
personnel (Smith, 2004). Calves purchased at local auctions are typically classified as
high risk for developing symptoms of BRD because theses cattle are of unknown origin,
commingled, and recently weaned from small cow-calf operations that seldom use
vaccination or other BRD prevention strategies (National Animal Health Monitoring
System, 1997). Stress and previous exposure to BRD pathogens may decrease vaccine
efficacy (Blecha et al., 1984; Loerch and Fluharty, 1999). The transportation stress period
can endure for as long as 15 d after arrival, based on serum hemolytic complement
concentration of calves (Purdy et al., 2000). Perino and Hunsaker (1997) indicated that
BRD vaccination on arrival at feedlots is equivocal at best. Other complications with onarrival administration of a modified live virus (MLV) vaccine may include reduced gain
performance caused by immunological challenges from antigens contained in a vaccine;
however, Stokka and Edwards (1990) reported no detrimental effects on gain of stressed
calves receiving a multiple polyvalent MLV vaccine. Current feedlot receiving protocols
include multivalent vaccination against BRD viruses within 48 h of arrival for high-risk
cattle, although the vaccine response and health benefit are questionable.
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Thus, our objective was to evaluate the effect of delayed (14 d) MLV vaccination
vs. on-arrival MLV vaccination on health, performance and serum infectious bovine
rhinotracheitis (IBR) titer levels of newly received high-risk stocker calves.
MATERIALS AND METHODS
Animal methods were approved by the University of Arkansas Animal Care and
Use Committee.
A total of 528 crossbred bull (n = 364) and steer (n = 164) calves (initial BW =
197 ± 2.4 kg) were purchased from a northern Arkansas auction barn and shipped
approximately 9 km to the University of Arkansas, Livestock and Forestry Branch
Station, near Batesville, AR. Cattle were received on 6 dates: September 9, 2004 (Block
1, n = 110), September 16, 2004 (Block 2, n = 98), January 10, 2005 (block 3, n = 80)
January 13, 2005 (Block 4, n = 80), February 14, 2005 (block 5, n = 70), and February
17, 2005 (Block 6, n = 90). Pen was designated as the experimental unit. For each date
block, 6 pens (3 treatments/pen) were used; therefore, each treatment was replicated a
total of 18 times. Because the number of animals per block varied, the number of animals
per pen ranged from 10 to 19, but within each block the number of animals assigned to
each treatment were equivalent.
Upon arrival (d -1), cattle were weighed (unshrunk), assigned a unique ear
identification tag, and arrival castrate status (bull or steer) was determined. Calves
remained commingled overnight, with access to hay and water. The following day (d 0),
bulls and steers were assigned to treatment based on castrate status, which was equally
distributed to treatments by assigning a similar number of bull and steer calves to each
treatment pen, with pens then assigned to treatment. Treatments included 1) initial

38

vaccination of a multivalent BRD MLV on arrival (d 0; AMLV), or 2) 14-d delayed
initial vaccination of the BRD MLV (DMLV). On d 0, calves were reweighed,
administered a clostridial bacterin with tetanus toxoid (Covexin-8; Schering-Plough
Animal Health, Inc., Elkhorn, NE), treated for internal and external parasites (Ivomec;
Merial, Iselin, NJ) and bull calves were castrated using the California banding method
(InoSol Co. LLC, El Centro, CA). Calves were administered 2 injections of a MLV BRD
vaccine 14 d apart. Arrival MLV calves were vaccinated with a 5-way MLV vaccine
containing isolates of IBR, bovine virus diarrhea (BVD) types I and II, bovine respiratory
syncytial virus (BRSV), and parainfluenza (PI3) in combination (Express 5; BoehringerIngelheim Vetmedica, Inc., St. Joseph, MO), whereas cattle assigned to the DMLV
treatment did not receive their initial 5-way MLV vaccination until d 14 of study.
In addition, the rectal temperature of each calf was determined using a digital
thermometer (Model No. M216, GLA Agricultural Electronics, San Luis Obispo, CA).
Calves with rectal temperatures of ≥40°C during the initial processing were administered
prophylactic treatment with tilmicosin phosphate (10mg/kg of BW, Micotil, Elanco
Animal Health, Indianapolis, IN) as described by Galyean et al. (1995). The percentage
of animals administered antibiotic on arrival (AMLV = 18.6%; DMLV = 23.4%) was not
different (P = 0.19), and these calves were excluded from subsequent morbidity analysis.
After cattle were randomly sorted, they were moved to 0.4-ha pens separated by
electrified fencing and provided a 16% CP supplement at 1% of BW (DM basis) and
free-choice access to Bermudagrass hay (10% CP, 56% TDN) for the entire 42-d
receiving study. The receiving supplement contained (as-fed basis) 67% corn, 19%
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cottonseed meal, 12.5% corn gluten feed, 1.5% limestone, and 0.04% Rumensin 80
(Elanco Animal Health) and supplied 368 g of CP and 200 mg of monensin/d.
To determine differences in BW gain performance, cattle were weighed (unshrunk) at 14-d intervals during the trial (d 14, 28, and 42). On d 14, both AMLV and
DMLV cattle received a booster vaccination of the clostridial bacterin with tetanus toxoid
(Covexin-8), AMLV cattle received a booster vaccination of the 5-way MLV (Express 5),
and DMLV cattle received their initial dosage of 5-way MLV (Express 5). Two weeks
later (d 28), DMLV cattle received their respective booster vaccination of 5-way MLV
(Express 5). At the conclusion of the 56-d receiving period, calves were implanted with
40 mg of trenbolone acetate and 8 mg of estradiol (Revalor G, Intervet Inc., Desoto, KS)
and the pasture phase of the study began.
Calves were observed each morning (0800 h) by Livestock and Forestry Branch
Station personnel for symptoms of respiratory illness (depression, lethargy, rapid
breathing, nasal or ocular discharge), slowness in going to the feedbunk when supplement
was provided, and a gaunt or emaciated appearance. Personnel were blinded to the
treatment allotment of each pen. Cattle with observed visual symptoms of BRD were
removed, restrained using a hydraulic squeeze chute (Flying W Inc., Watonga, OK) and
considered morbid if their rectal temperature was ≥40°C. Morbid animals from both
treatments were administered antibiotic therapy following the same predetermined
antibiotic treatment protocol which included initial antibiotic therapy with tilmicosin
phosphate (Micotil, 10 mg/kg of BW). Cattle were reevaluated 72 h later, and those with
a rectal temperature of ≥40°C were considered morbid a second time and administered a
second antibiotic treatment with enroflaxacin (Baytril, Bayer Animal Health, Shawnee
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Mission, KS). After reevaluation, cattle requiring treatment a third time were
administered florfenicol (Nuflor, Schering-Plough Animal Health, Summit, NJ). After 3
treatment events, cattle were considered non-responsive and no further antibiotic therapy
was administered regardless of the symptoms. Cattle were returned to their respective
home pen immediately following each antibiotic treatment. Treatment data recorded for
individual animals included the treatment date and the amount, type and cost of antibiotic
administered.
Blood samples were collected from 3 randomly selected animals in each pen to
evaluate serum IBR titer levels. Blood was collected via jugular venipuncture from the
same animals on d 0, 14, 28, and 42 for AMLV and d 0, 28, 42, and 56 for DMLV and
stored in 15-mL Vacutainer tubes (BD Inc., Franklin Lakes, NJ). Blood was placed in a
refrigerator at 4°C for 6 h after collection, and serum was separated by centrifugation at
1,000 × g for 30 min. Serum was then decanted and stored at -5°C for subsequent
analysis, when all samples from the entire study were compiled. Once all serum samples
were collected, they were packaged and shipped overnight to the diagnostic laboratory
(Oklahoma Animal Disease Diagnostic Center, Stillwater, OK) for assay of IBR virus
antibodies by the serum neutralization method, as described by Rosenbaum et al. (1970).
Titers were reported as the reciprocal of the greatest dilution of serum that provided
complete protection of the cells. The lowest dilution of serum tested was 1:4, whereas the
greatest dilution of serum tested was 1:256. Serum that did not provide protection at the
1:4 level were reported as <4, and was considered negative for seroconversion to IBR.
Samples with a reported serum neutralization value of 4 were considered positive for
seroconversion to IBR. Titers were evaluated to determine differences in the percentage
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of animals in each treatment with positive seroconversion to IBR. According to
laboratory results (Oklahoma Animal Disease Diagnostic Center), samples with a
reported serum neutralization value of <4 were considered negative and those 4 were
considered positive for IBR seroconversion. Titers <4 were assigned a value of 0, whereas
titers 4 were assigned a value of 1 and analyzed by

2

analysis to determine the

percentage positive for differences in treatment by day. Percentage of IBR seroconversion
was compared on both a receiving-day basis and a vaccination timing-equivalent basis.
Receiving-day IBR titer comparisons were made from samples collected on d 0, 28, and
42. Vaccination timing-equivalent comparisons were made for IBR titers based on the
number of days postinitial vaccination (d 0 AMLV vs. d 14 DMLV) and postbooster
vaccination (d 14 AMLV vs. d 28 DMLV). Therefore, a blood sample was collected from
DMLV calves after the receiving period had ended (d 56) to allow a final vaccine timingequivalent comparison (d 42 AMLV vs. d 56 DMLV).

Statistical Analysis
Treatment data were analyzed as a randomized complete block design. Pen was identified
as the experimental unit. Date of shipment arrival was treated as the random block effect
in the model. The treatment x block interaction was used as the denominator mean square
for the treatment effect test. Gain performance data, days to first pull, and treatment cost
were analyzed using PROC MIXED (SAS Inst. Inc., Cary, NC). Initial BW was used as a
covariate, and arrival castrate status (steer vs. bull) was used as a source of variation in
the model to minimize the unwanted effects of arrival BW and castrate status on
treatment outcome.

42

RESULTS AND DISCUSSION

Performance and Health
Body weight and ADG during receiving and grazing are presented in Table 1.
Body weight of calves in the DMLV treatment was greater (P = 0.007) on d 14 and
tended to be greater (P = 0.07) on d 42 than those in the AMLV treatment. Average daily
gain was greater (P = 0.007) for DMLV cattle compared with AMLV from d 0 to 14 of
the study (1.16 vs. 0.88 ± 0.22 kg/d). For the first 14 d of the study, AMLV had been
administered an MLV vaccine, whereas DMLV had not yet received an initial MLV
vaccine and could be considered a negative control. The difference in gain performance
remained for the overall 42-d receiving period, with AMLV averaging 0.65 vs. 0.75 (±
0.09) kg/d for DMLV (P = 0.05). Average daily gain from d 14 to 28 was not different (P
= 0.45). The performance reduction in AMLV cattle from d 0 to 14, and in DMLV cattle
from d 14 to 28, suggests that the initial physiological response to an MLV vaccine may
elicit consequences that are temporarily detrimental to growth performance. No
differences (P = 0.15) were detected for pasture ADG during the subsequent grazing
period.
Mass antibiotic metaphylaxis was not used in the current study; however, cattle
were given prophylactic antibiotic treatment on arrival if the rectal temperature was
40.0°C. Galyean et al. (1995) reported that regardless of whether newly received calves
were mass medicated with tilmicosin or received tilmicosin when the rectal temperature
was 39.7°C, there was a similar reduction in percentage of calves treated for BRD
compared with control calves. Based on our protocol, a similar (P = 0.19) number of
animals for AMLV (18.6%) and DMLV (23.4%) qualified for on-arrival antibiotic
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treatment, and there was no difference (P = 0.83) in rectal temperature on arrival
(averaging 39.6°C; Table 2). Of the calves included in the morbidity analysis, 90.0% of
initial BRD treatment episodes for AMLV and 88.8% of treatment episodes for DMLV
had occurred by d 14 of the study (Figure 1). There were no differences (P 0.16) in the
number of days to first treatment, mortality, or treatment cost for morbidity. The initial
treatment rate for BRD was high (AMLV = 71.5%, DMLV = 63.5%) but not different (P
= 0.12; Table 2). The high rate of BRD morbidity is not uncommon in calves purchased at
local auction barns and received at the Livestock and Forestry Branch Station. In this
study, on-arrival MLV vaccination did not seem to be advantageous for either gain
performance or disease prevention based on our results.
Duff et al. (2000) used 2 studies to evaluate the effects of viral vaccine route of
administration and vaccine timing on the health and performance of newly received beef
cattle. In the first study, ADG was greater for calves receiving an intranasal vaccine
compared with an i.m. MLV IBR-PI3 vaccine but was not greater than for unvaccinated
control calves, yet the rate of morbidity did not differ. In the second study, Duff et al.
(2000) reported no differences in BW gain among nonvaccinated calves, calves with 4way MLV vaccination delayed until d 7, calves that received an intranasal IBR-PI3
vaccine administered on d 0 with 4-way MLV vaccination delayed until d 7, or calves that
received a 4-way MLV vaccination on both d 0 and 7. However, G:F tended to be
improved for vaccinated calves vs. nonvaccinated calves. Kreikemeier et al. (1996b)
found that during the initial 21 d of the feedlot receiving period, calves vaccinated with a
killed virus on the farm before weaning and revaccinated with a killed virus at the time of
commingling at a sale barn tended to gain faster than calves given an MLV upon arrival
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at the feedyard and revaccinated 21 d after feedyard arrival. Preweaning BRD vaccination
is certainly preferable; however, newly received calves of unknown origin that are
allowed a period to adjust to their new environment and recover from previous stressors
may be better suited to respond to MLV vaccination. Kreikemeier et al. (1996a) used a 2
× 2 factorial arrangement of treatments, which included mass medication with either
tilmicosin phosphate or chlortetracycline or no mass medication, and routine processing
on either d 1 or 21. Processing included a growth implant, an 8-way clostridial vaccine, a
4-way MLV vaccine, and an injectable dewormer. For the entire 56-d receiving period,
calves that received processing on d 1 gained faster than calves with processing delayed
until d 21. This is inconsistent with our results of increased ADG for DMLV; however,
their study also included delayed administration of a growth implant and dewormer for 21
d, which could explain the difference in results.
No differences were detected (P > 0.11) for the effects of MLV vaccination
timing on initial treatment for BRD-associated morbidity, percentage of calves retreated
for BRD, mortality, or treatment cost (Table 2). The overall consensus among animal
health professionals and veterinarians seems to support arrival vaccination against BRD
as an effective method of disease prevention, and a study by Hansen et al. (1992) supports
this view when the morbidity rate is high. However, several groups have reported a
neutral outcome when vaccinating newly received beef cattle for BRD (Bateman, 1988;
Johnson et al., 1988; Duff et al., 2000). Martin et al. (1982) reported an increased risk of
mortality when a respiratory vaccine was administered within 14 d of arrival. In that
study, delaying the BRD vaccination in calves for 14 d from arrival decreased the
mortality and treatment cost in cattle fed corn silage-based diets; however, no vaccination
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timing differences were noted when cattle were fed dry hay-based diets. In the current
study, the initial morbidity rate for BRD was high for both AMLV and DMLV (71.5 and
63.5%, respectively) but did not differ between treatments (P = 0.12). Overall, 93% of
BRD pulls occurred within the first 14 d of receiving (Figure 1). These data suggest little
or no advantage of administering a 5-way MLV vaccine to high-risk stocker cattle on
arrival. The high morbidity rate (Figure 1) observed before d 14 indicates that few
changes in the receiving protocol could have affected morbidity rates.
IBR Titers
Serum titers are used as an indication of antibody protection against a specific
pathogen, thereby providing an indication of vaccine efficacy (Callan, 2001). It is poorly
understood how acquired antibody levels may be affected by the timing of vaccination
before or during the receiving period; however, stress is known to compromise immune
function (Chirase et al., 2004), and label guidelines according to the vaccine
manufacturers recommend that vaccination of stressed cattle be avoided.
No differences (P = 0.94) were detected for the percentage of positive IBR titers on d 0
(Figure 2), and positive seroconversion was low (AMLV = 8.8%; DMLV = 8.4%). On the
basis of the vaccination timing-equivalent comparison, DMLV resulted in a greater
percentage (P 0.03) of animals seropositive to IBR 28 and 42 d after the initial
vaccination (Figure 2). When treatments were compared at the conclusion of the
receiving period (d 42) the DMLV treatment exhibited greater (P = 0.01) IBR virus
antibody titer seroconversion. Results of IBR titer level comparisons suggest an improved
vaccine response for DMLV. Natural disease exposure and subsequent host immune
response may have contributed to the increased IBR antibody titers in this study;
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however, the extent to which natural exposure affected IBR seroconversion is unknown.
No difference in arrival (d 0) IBR titer levels were detected (P 0.95) in animals that
became morbid once or twice compared with those never treated during the study (data
not shown). Martin et al. (1999) reported seroconversion of BRSV and BVD viruses from
d 0 to 28 in unvaccinated animals; however, mean IBR titers were low and were not
different on either d 0 or 28 in unvaccinated calves both treated for BRD and not treated.
Measurement of neutralizing antibody titers has been reported to provide an indication of
the amount of BVD protection present in calves (Bolin and Ridpath, 1995) and has been
positively correlated with disease prevention (Howard et al., 1989). This has not been
studied as extensively in IBR; thus, further research on the role IBR titers may relate to
BRD protection in the field is warranted.
Delaying initial MLV vaccination by 14 d improved the gain performance of
high-risk, newly received cattle during the receiving period compared with MLV
vaccination on d 0. Morbidity rate or cost associated with BRD was not different.
Moreover, serum IBR titers were greater when initial MLV vaccination was delayed.
Because no differences in morbidity or mortality were detected for the 2 treatments, and
performance for DMLV cattle was slightly improved, results of the current study suggest
an economic advantage to delaying initial MLV vaccination until 14 d after arrival.
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Table 1. Effect of BRD vaccination timing on performance of newly received cattle.
On Arrivala

Delayeda

SEb

P-Value

BW, kg d
Day 0

197.7

195.9

2.42

0.33

Day 14

208.6

212.7

3.03

0.007

Day 28

217.4

219.9

2.93

0.16

Day 42

224.4

228.1

4.08

0.07

ADG, kg/d c
D 0 to 14

0.88

1.16

0.22

0.007

D 14 to 28

0.61

0.53

0.15

0.45

D 28 to 42

0.45

0.56

0.10

0.12

D 0 to 42

0.65

0.75

0.09

0.05

0.89

0.84

0.08

0.15

Pasture ADG, kgd
a

Treatments were vaccination of incoming stocker cattle with Express® 5 (Boehringer

Ingelheim) modified live IBR, PI3, BRSV and BVD type I and II vaccine either on
arrival at initial processing (d-0) or on d-14. Cattle were re-vaccinated 14 d following
initial vaccination.
b

Standard Error of the mean (n = 524).

c

All analysis (except d-0 BW) was conducted using BW and gender on d-0 as a covariate.

d

Grazing performance calculated subsequent to the 42 d receiving period.

50

Table 2. Effect of BRD vaccination timing on morbidity, mortality and treatment
cost of newly received cattle.
On Arrivala
Rectal Temperature on d-0, C

Delayeda

SEb

P-Value

39.61

39.56

0.23

0.83

Initialc

75.3

70.2

0.10

0.21

Re-treatd

29.4

35.1

0.11

0.08

Days to 1st treatment

5.7

5.1

1.10

0.44

Death loss, %

2.3

0.8

0.75

0.19

10.29

10.64

2.36

0.75

BRD Treatment, %

BRD Treatment Cost, $e
a

Treatments were vaccination of incoming stocker cattle with Express® 5 (Boehringer-

Ingelheim) modified live IBR, PI3, BRSV and BVD type I and II vaccine either on
arrival at initial processing (d-0) or on d-14. Cattle were re-vaccinated 14 d following
initial vaccination.
b

Standard Error of the mean (n = 524).

c

Initial, cattle with observed symptoms of BRD and temperature in excess of 40° C were

injected with Micotil (Elanco) at 1.5 cc/ 45.5 kg BW.
d

Re-treat, 72 h following initial, cattle with observed symptoms of BRD and temperature

in excess of 40° C were injected with Baytril (Bayer) at 4.0 cc/ 45.5 kg BW.
e

Treatment cost for BRD assuming value of Micotil $1.10/cc and Baytril $0.53/cc.
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ABSTRACT: Stress, commonly associated with weaning, marketing, and shipment of
feeder cattle can compromise immune function, and vaccine administration during
immunosuppression may reduce vaccine efficacy and calf growth. Four treatments were
compared in a 2  2 factorial arrangement to evaluate the effect of on-arrival (d 0) vs.
delayed (d 14) administration of clostridial (CLOS) and respiratory (RESP) vaccines on
health, performance, bovine viral diarrhea virus (BVDV) antibody titers, and
physiological immune measurements of high-risk, newly received calves. Crossbred bull
and steer calves (n = 263) were weighed (239 ± 1.2 kg), stratified by gender, and
randomly assigned to vaccination treatment: 1) arrival CLOS, arrival RESP (ACAR); 2)
arrival CLOS, delayed RESP (ACDR); 3) delayed CLOS, arrival RESP (DCAR); and 4)
delayed CLOS, delayed RESP (DCDR). Body weight and blood samples were collected
on d 0, 14, 28, 42, and 56. Average daily gain did not differ (P ≥ 0.34) averaging 0.98,
0.93, 0.95, and 0.91 kg/d for ACAR, ACDR, DCAR and DCDR, respectively, for the
entire 56 d trial. Vaccination timing did not affect morbidity (P ≥ 0.23); however, there
tended to be a CLOS timing effect (P = 0.07) and RESP timing effect (P = 0.09) on d to
initial bovine respiratory disease (BRD) treatment. Average d to initial BRD treatment
were less for ACAR (6 ± 0.8 d) compared to DCDR (8 ± 0.8 d; P = 0.01). Greater white
blood cell (WBC) counts were observed for DCDR than ACDR (P = 0.01), with ACAR
and DCAR being intermediate. Serum cortisol concentrations were greater on d 0 than d
14 (P < 0.01) or d 28 (P = 0.01) but no treatment  day interaction (P = 0.21) was
observed. Timing of RESP administration affected (P = 0.001) serum BVDV type I titer
levels, with greater (P < 0.01) levels in calves receiving RESP vaccine on arrival.
Delaying CLOS or RESP vaccination did not affect gain or morbidity in high risk, newly
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received stocker calves. Calves administered RESP vaccine on d 0 developed antibody
titers to BVDV type I earlier than delayed RESP treatments. Total WBC count was
greatest when RESP and CLOS vaccination were delayed (DCDR).
INTRODUCTION
Bovine respiratory disease (BRD) is the leading cause of morbidity and mortality
according to a recent survey of US feedlots (Woolums et al., 2005), resulting in
significant economic losses to the beef cattle industry. Calves purchased at local auction
markets throughout the southeastern US are typically classified as high-risk for
developing signs of BRD because these cattle are of unknown origin and recently weaned
from small cow-calf operations that seldom utilize vaccination or other BRD prevention
strategies (NAHMS, 1997). These high-risk cattle may be suffering stress effects
resulting from a combination of commingling, transport, nutritional, weaning and
environmental stressors that can compromise the immune system (Smith, 2004), and the
transportation stress period can endure for as long as 15 d post-arrival based on serum
hemolytic complement concentration (Purdy et al., 2000). Vaccination against viral
and/or bacterial pathogens that contribute to BRD can be an effective preventative
strategy; however, vaccine efficacy may be reduced if administered during
immunosuppression (Callan, 2001), and a review of field vaccine efficacy by Perino and
Hunsaker (1997) suggested that administering BRD vaccination at arrival in North
American feedlots was generally not supported by published research. Other
complications with on-arrival vaccination may include reduced gain performance
(Chirase et al., 2001; Richeson et al., 2008), perhaps due to immunological challenge
from vaccine antigens during a period when calves may be experiencing stress-induced
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immunosuppression. Thus, our objective was to evaluate the effect of delaying
respiratory and/or clostridial vaccination (d 14 vs. arrival) on health, performance, serum
bovine viral diarrhea virus (BVDV) type I titers, and physiological stress and immune
measures in high-risk, newly received calves.
MATERIALS AND METHODS
Animal methods were approved by the University of Arkansas (UA) Animal Care
and Use Committee.
Crossbred bull (n = 207) and steer (n = 57) calves (BW = 239 ± 1.2 kg) were
procured by an order buyer from multiple auction markets located in western Arkansas
and eastern Oklahoma and shipped to the UA Agricultural Experiment Station located
near Savoy. These calves were likely commingled extensively from numerous herds and
were experiencing other stressors described by Smith (2004) and thus would be
considered high-risk for BRD. Three separate shipment dates representing each block in
the experimental model were received on February 12 (Block 1, n = 90), March 1 (Block
2, n = 91), and April 17, 2007 (Block 3, n = 83). Calves in each block were divided into 8
pens (10 to 12 calves/pen); thus, each of the 4 treatments were replicated 6 times.
Upon arrival, cattle within each block were weighed, assigned a unique ear
identification tag and gender was determined (bull or steer). Within gender (bull or steer),
calves were randomly distributed to 1 of 8 pens. The 8 pens had been randomly assigned
to 1 of 4 vaccination-timing treatments (Table 1). Treatments were arranged as a 2  2
factorial with Clostridium chauvoei, septicum, novyi, and sordellii and perfringens types
C & D bacterin-toxoid in a special oil adjuvant (Alpha 7, Boehringer Ingelheim
Vetmedica, St. Joseph, MO; CLOS) and infectious bovine rhinotracheitis, bovine viral
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diarrhea virus type 1a (Singer strain) and type 2a (Bolin 296 strain), parainfluenza3, and
bovine respirtatory syncytial virus modified-live virus vaccine (Express 5, Boehringer
Ingelheim Vetmedica, St. Joseph, MO; RESP) administered either on arrival (d 0) or
delayed (d 14). This resulted in the 4 treatments: 1) arrival CLOS and RESP (ACAR), 2)
arrival CLOS and delayed RESP (ACDR), 3) delayed CLOS, and arrival RESP (DCAR),
and 4) delayed CLOS and RESP (DCDR). Treatments were not arranged spatially
according to vaccination treatment; because of random treatment assignment there were
instances where vaccinated and non-vaccinated calves had fence-line contact during the
study. However, using the same RESP vaccine as in the current study, Kleiboeker et al.
(2003) concluded that shedding of BVDV type I or II in calves after vaccination was
either nonexistent or undetected and did not result in transmission of either BVDV
genotype in pregnant contact control cows.
In addition to receiving their assigned vaccination treatment on d 0, calves were
treated for internal and external parasites (Cydectin, Fort Dodge Animal Health, Fort
Dodge, IA), branded, administered metaphylactic antibiotic treatment with tilmicosin
(Micotil, Elanco Animal Health, Indianapolis, IN) according to BW, and bull calves were
surgically castrated. An ear notch sample was collected from each animal to test for
persistently infected BVDV (Cattle Stats, Oklahoma City, OK). One animal in Block 1
was identified as such and was removed from the study pen and quarantined on d 3.
Furthermore on d 0, blood samples from 5 randomly selected animals in each pen were
drawn intravenously from a jugular vein into untreated vacuum tubes (Vacutainer, BD
Inc., Franklin Lakes, NJ) for subsequent analysis of serum cortisol concentrations and
BVDV type I titer levels (plain tube). A second blood sample (10 mL) was collected into
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vacuum tubes containing EDTA (BD, Inc.) for determination of white blood cell (WBC)
total and differential counts. Cattle were then moved to their assigned 0.45-ha pens and
provided 0.9 kg/calf (as-fed basis) of a receiving supplement (20.6% CP, DM basis;
Table 2) and free-choice access to bermudagrass hay (14.5% CP, 33.6% ADF, 68.3%
NDF, and 7.9% ash, DM basis). Supplement was offered daily at 0800 h and increased to
a maximum of 1.8 kg/calf daily as calves began consuming the supplement.
A booster vaccination of RESP was administered 14 d following initial RESP
vaccination according to treatment protocol (Table 1). Cattle were re-weighed, unshrunk,
before offering supplement at 14-d intervals during the trial (d 14, 28, 42, and 56) to
determine interim and overall differences in BW gain performance. The same 5 animals
per pen selected for blood collection upon arrival were similarly sampled on d 14, 28, 42,
and 56.
Blood in the plain tubes was centrifuged at 2,100  g for 20 min at 20°C, and
serum was stored frozen at -20°C until analyzed. Serum cortisol concentrations were used
as an indication of overall physiological stress and were determined using commercially
available RIA kits (Coat-A-Count, DPC, Los Angeles, CA) with an intra- and inter-assay
CV of 1.04 and 23.0%, respectively. Sensitivity of the assay was 0.2 μg/100 mL. The use
of this assay has been previously validated (Godfrey et al., 1991). Frozen serum samples
were shipped on ice via overnight parcel service to the Oklahoma Animal Disease
Diagnostic Laboratory (Stillwater) for determination of serum neutralizing antibodies for
BVDV type I. Whole blood collected in tubes containing EDTA was kept refrigerated
and used within 24 h to determine concentrations (n cells/µL) of total WBC,
concentrations and percentages of differential WBC (lymphocytes, neutrophils,

57

monocytes, eosinophils, and basophils), total red blood cells, hemoglobin, hematocrit,
and platelets with an automated hematology analyzer (Cell-Dyn 3500 system, Abbott
Laboratories, Abbot Park, IL) standardized for analysis of bovine blood.
After arrival metaphylaxis with tilmicosin (Micotil, Elanco Animal Health,
Indianapolis, IN), a 48 h post-treatment interval (PTI) was implemented; therefore, calves
were observed each morning beginning on d 3 of the study for clinical signs of
respiratory illness by 2 experiment station personnel having a combined 20-yr experience
evaluating cattle with BRD. These personnel were present during processing and were
not blinded to treatment; however, no records left at the facility identified treatment
assignments. Signs used to identify respiratory illness included depression, nasal and
ocular discharge, cough, increased respiratory rate and poor appetite. Cattle with 2 or
more visual signs of BRD were pulled and considered morbid if rectal temperature was ≥
40°C. Morbid animals were given antibiotic therapy following a pre-determined
antibiotic treatment protocol and returned to the home pen. A re-check temperature was
taken 48 h following initial treatment with florfenicol (Nuflor, Schering-Plough Animal
Health, Summit, NJ). If the re-check temperature was ≥ 40°C, a second antibiotic
treatment with ceftiofur crystalline free acid (Excede, Pfizer Animal Health, New York,
NY) was administered. A 72 h PTI was implemented for cattle administered ceftiofur
crystalline free acid and rectal temperature was re-evaluated. If the re-check temperature
was ≥ 40°C, a third and final antibiotic treatment with danofloxacin mesylate (A180,
Pfizer Animal Health) was administered and repeated 48 h following the first injection.
Cattle that continued to display BRD symptoms after the third treatment were considered
chronically ill and no further antibiotic treatment was administered. If at any time a re-
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check temperature was < 40°C, the animal was left untreated unless further symptoms
developed. Treatment data recorded for individual animal included treatment date, rectal
temperature, and the amount and type of antibiotic administered.
Titers were evaluated to determine differences in the concentration of BVDV type
I antibodies and the percentage of animals in each treatment with positive seroconversion
to BVDV type I using the serum neutralization method as described by Rosenbaum et al.
(1970). Titers were reported as the reciprocal of the greatest dilution of serum to provide
complete protection of cells. The lowest dilution of serum tested was 1:4; whereas, the
greatest dilution tested was 1:256. Serum that did not provide protection at the 1:4 level
was reported as < 4, and was considered negative for seroconversion to BVDV. Samples
with a reported serum neutralization value of ≥ 4 were considered positive for
seroconversion to BVDV. For the titer level analysis, the reported values were log2
transformed and statistically evaluated. To analyze for percentage seroconversion to
BVDV type I, titer values < 4 were assigned 0 (negative); whereas, titers ≥ 4 were
assigned a value of 1 (positive). Receiving-day BVDV titer comparisons were made from
samples collected on d 0, 14, 28, and 42. Vaccination timing-equivalent comparisons
were made for BVDV titers based on the number of d post-initial RESP vaccination (d 0
ACAR, DCAR vs. d 14 ACDR, DCDR) and post-booster vaccination (d 14 ACAR,
DCAR vs. d 28 ACDR, DCDR).
Statistical Analysis
Performance and morbidity data were analyzed as a randomized complete block
design using the PROC MIXED procedure of SAS (SAS Inst., Inc., Cary, N.C.). Pen was
considered the experimental unit. The class statement included block (date of arrival),
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treatment, and replicate. Block and block  replicate  treatment were treated as random
effects in the model. Single degree of freedom orthogonal contrasts evaluating effects of
CLOS timing, RESP timing, and the interaction were used. If the interaction was
significant (P ≤ 0.10), treatment means were separated with a t-test using the PDIFF
option in SAS. Cortisol, total and differential WBC, total red blood cell, hemoglobin,
hematocrit, platelets and BVDV type I titer data were analyzed using the PROC MIXED
procedure with repeated measures. Pen was considered the experimental unit for these
data. The model included treatment, day and treatment  day. Block, replicate, treatment,
and day were used in the class statement. Block was the random variable, and the
repeated statement was day with block  treatment within replicate as the subject. The
covariance model structure used was AR(1). Contrasts for the repeated measures data
included CLOS timing, RESP timing, their interaction, and linear, quadratic, cubic, and
for some variables quartic effects of day.
RESULTS AND DISCUSSION
Performance
No differences (P ≥ 0.34) in ADG were observed during the 56 d receiving period
(Table 3). Experiments involving vaccination timing of newly received calves are
conflicting. In one trial (Richeson et al., 2008), calves that received delayed (14 d)
vaccination of a modified-live virus (MLV) respiratory vaccine (Express® 5) had greater
ADG. Kreikemeier et al. (1996) observed that during the initial 21 d of the feedlot
receiving period, calves vaccinated for BRD with a killed-virus at the farm prior to
weaning and re-vaccinated with a killed virus at the time of commingling at a salebarn
tended to gain faster than calves given a MLV upon arrival at the feedyard and
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revaccinated 21 d after feedyard arrival. Conversely, Duff et al. (2000) reported no
differences in BW gain among 4 vaccination treatments, including 1) no vaccine
(control); 2) delayed 4-way [infectious bovine rhinotracheitis (IBR), BVDV,
parainfluenza3 (PI3), bovine respiratory syncytical virus] MLV vaccination until d 7; 3)
intranasal IBR-PI3 administered on d 0 with delayed 4-way MLV vaccination until d 7;
and 4) 4-way MLV vaccination on both d 0 and d 7. Clostridial vaccines contain a special
and often proprietary adjuvant used to enhance the immune response to the killed
antigens contained in the vaccine; however, the effect of different adjuvants on animal
performance deserves consideration. Chirase et al. (2001) conducted 2 experiments to
evaluate the effects of clostridial vaccines and injection site on performance. In Exp. 1,
calves given an injection of saline subcutaneously prescapula (control) had greater (P <
0.01) ADG than calves injected s.c. prescapula with Vision 7 (7-way clostridial, Intervet
Inc. Millsboro, DE) or Ultra 7 (7-way clostridial, Pfizer Animal Health) but not Alpha 7
injected subcutaneously either prescapula or in the ear, which is the clostridial vaccine
used in the current study. Spurlock (1997) reported that repeated immune stimulation can
result in decreased growth of an animal because nutrients are preferentially utilized for
immune and homeostatic pathways. Conflicting results of vaccination on receiving cattle
performance may be due to a number of host factors such as vitamin/mineral status,
vaccination history, and the stress level of a particular group. Further research is needed
to evaluate the effects of vaccination on animal performance during the receiving period.
Health
The majority of the cattle became sick with 69% of all calves being treated at
least one time for BRD (Table 4), but morbidity rates were not different among
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treatments (P ≥ 0.23). Likewise, no differences were observed in the number of 2nd (P ≥
0.18) or 3rd (P ≥ 0.37) BRD treatments. Combined death loss (1.9%) did not differ (P ≥
0.64) among treatments. There was a vaccine type × timing interaction (P = 0.05) for the
percentage of chronic animals, ACDR had a greater percentage of chronic animals than
ACAR (P = 0.04) and DCDR (P = 0.08), but not DCAR (P = 0.26).
There was a tendency for CLOS (P = 0.07) and RESP (P = 0.09) timing effects on
days to initial BRD treatment. Days to initial BRD treatment were fewer (P = 0.01) for
ACAR (6 ± 0.76 d) than DCDR (8 ± 0.76 d). This difference may be a result of additive
effects of on-arrival vaccination on the visual symptoms of BRD in cattle receiving both
CLOS and RESP on d 0 (ACAR) vs. cattle receiving no vaccine until d 14 (DCDR). The
increase of early visual BRD symptoms in cattle receiving vaccination on arrival did not
translate to increased (P ≥ 0.23) morbidity rates. However, there was a numerical
difference; 73.4% of cattle receiving RESP on-arrival required treatment for BRD
compared to 65.1% of cattle that received delayed RESP vaccination. Furthermore,
CLOS (P = 0.01) and RESP (P = 0.05) timing affected rectal temperature at the time of
initial antibiotic treatment. Delaying either vaccine resulted in a greater rectal
temperature at the time of initial antibiotic treatment. Because DCDR calves were pulled
later than the other treatments, discrepancy in disease stage may explain the greater rectal
temperature at the time of initial BRD treatment. There was also an impact (vaccine type
× timing interaction, P = 0.05) on the d to treatment with the second antibiotic; DCDR
calves were treated later (d 13 ± 1.3) than calves on the other treatments (d 9 ± 1.3).
BVDV Type I Antibody Titers
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Two separate comparison methods were used to evaluate differences in BVDV
type I titers: 1) trial-d basis and 2) equivalent-d post-RESP vaccination basis.
Furthermore, results were analyzed and reported as either antibody concentration or
percent positive seroconversion as described previously in the Materials and Methods.
Trial-Day Basis Comparison. As anticipated there was a treatment  day
interaction (P ≤ 0.04) for BVDV type I titers for both analyses. On d 14, BVDV type I
titer levels for ACAR were greater than ACDR (P = 0.001) or DCDR (P = 0.01, Figure
1). On d 28, both treatments administered RESP on-arrival (ACAR and DCAR) had
greater (P ≤ 0.005) BVDV type I titers than treatments administered delayed RESP
vaccination (ACDR and DCDR). No treatment differences (P ≥ 0.10) existed on d 42.
Results were similar when trial-day basis titer data were analyzed as percent
seroconversion to BVDV type I (Figure 2). Positive seroconversion to BVDV type I was
faster (P = 0.01) when RESP was administered on d 0. On d 14 and 28, ACAR and
DCAR had greater percentage seroconversion than ACDR or DCDR; however, by d 42
of the trial essentially all animals had positive seroconversion to BVDV type I.
Equivalent-Day, Post-RESP Comparison. There was no treatment  day
interaction (P ≥ 0.82) for the equivalent-day post-RESP comparison method. The overall
log2 concentration of BVDV type I antibody was 5.2, 4.9, 5.0, and 4.7 for ACAR, ACDR,
DCAR and DCDR treatments, respectively, but not different (P = 0.68). Likewise, no
differences (P = 0.56) were detected when analyzed as percent seroconversion by the
equivalent-day post-RESP comparison.
The BVDV titer results in this study suggest that high-risk, newly received calves
administered RESP vaccination on-arrival are able to respond adequately to RESP
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vaccination despite the typical stress and immune challenges present during the initial 14
d of receiving. Natural disease exposure and subsequent host immune response may have
affected BVDV type I antibody titers; however, the extent to which this may have
occurred is unknown. Measurement of BVDV neutralizing antibody titers has been
reported to provide an indication of the amount of BVDV protection present in calves
(Bolin and Ridpath, 1995) and has been positively correlated with disease prevention
(Howard et al., 1989). Although calves administered RESP on arrival developed titers to
BVDV type I faster, there was not a decrease (P ≥ 0.23) in morbidity or increase in
protection as was reported in other studies (Bolin and Ridpath, 1995; Howard et al.,
1989). However, Bolin and Ridpath (1995) and Howard et al. (1989) were both BVDV
challenge studies where calves were only exposed to BVDV; whereas in our study the
specific agent causing morbidity was not tested and therefore unknown. In the current
study it is likely that more than 1 viral or bacterial pathogen, or both, was causing
morbidity, which may or may not have been vaccinated against.
Total and Differential WBC Count
There was no treatment  day interaction for total WBC count (P = 0.97). There
tended to be a main effect of CLOS timing (P = 0.08) on total WBC count (Table 5).
Overall, delaying CLOS resulted in greater WBC counts. There was also a vaccine type 
timing interaction (P = 0.06); DCDR had greater WBC counts than ACDR (P = 0.01),
and ACAR and DCAR were intermediate. The greater WBC levels recorded for DCDR
may indicate that these cattle had greater occurrence of pathogenic infection. However,
greater total WBC count may also indicate that an animal has increased ability to mount
an innate or adaptive immune response to a foreign antigen, which is a key goal of
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vaccination. There were effects of day of sampling on differential percentages (Figure 3),
concentrations (data not shown), and total WBC count (Figure 4). The percentage of
lymphocytes (quartic, P < 0.001), monocytes (quartic, P = 0.02), eosinophils (linear, P <
0.001), and the WBC count (quartic, P < 0.001) increased as the study progressed; while
the percentage of neutrophils decreased (quartic, P < 0.001) over time. Concentrations of
differential WBC reacted similarly with number of neutrophils decreasing (quadratic, P <
0.001), and numbers of lymphocytes (quadratic, P < 0.001), monocytes (quadratic, P =
0.001), eosinophils (linear, P < 0.001), and basophils (linear, P < 0.001) increasing as the
study progressed. Previous studies measuring total leukocytes before and after transport
observed different results. Blecha et al. (1984) reported greater total leukocyte
concentration at unloading and 7 d after receiving in transported steers vs. nontransported controls. In contrast to our results, Stanger et al. (2005) observed a transient
decrease in total leukocyte count when measured 48 h prior to, 72 h following and 216 h
following transport of Bos indicus steers. The neutrophil:lymphocyte ratio (N:L),
reported as an indicator of shipping stress in pigs (McGlone et al., 1993) and social stress
in chickens (Gross and Siegel, 1983), was also affected by day of sampling (quartic, P ≤
0.05). As the study progressed, the N:L decreased; therefore, physiological stress early in
the receiving period seemingly elevated the N:L ratio of calves across all treatments.
There were no treatment  day interactions (P ≥ 0.18) for differential percentages
or concentrations of WBC. Overall, CLOS timing affected some differential percentages
and concentrations. Delaying CLOS increased (P ≤ 0.02) the percentage and
concentration of lymphocytes and decreased (P ≤ 0.05) the percentage of monocytes, and
the percentage and concentration of eosinophils. The N:L tended to be affected by a
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vaccine type × timing (P = 0.10) interaction; DCDR had the smallest N:L. Therefore,
postponing both vaccines 14 d may have reduced stress.
Red blood cells and platelets were greatest (P = 0.02) in calves administered
delayed RESP vaccination (Figure 4). Red blood cells (quadratic, cubic and quartic
effects of day, P ≤ 0.05), hemoglobin (linear, quadratic, cubic and quartic effects of day,
P ≤ 0.05), and hematocrit (quadratic and cubic effects of day, P < 0.001) were least on d
14. Platelet concentrations were the least on d 56 (quadratic, P = 0.01).
Serum Cortisol
There was no treatment  day interaction (P = 0.21) for serum cortisol
concentrations (Figure 5), nor were there any treatment differences (P ≥ 0.53); however,
there was a significant day effect (P = 0.002) on cortisol concentrations. Cortisol
concentrations averaged 3.04 µg/100 mL on d 0 and declined on d 14 (2.43 µg/100 mL, P
< 0.001) and d 28 (2.57 µg/100 mL, P = 0.01), suggesting that physiological stress was
greatest during the first 14 d of the receiving period. Several studies report stress induced
increases in cortisol concentrations (Kegley et al., 1997; Tyler and Cummins, 2003;
Gupta et al., 2005), and Anglen et al. (2003) observed animals that underwent restraint
stress failed to mount a normal immune response which resulted in increased
susceptibility to a subsequent pathogen challenge. Crookshank et al. (1979) reported that
corticosteroids were most responsive to transport stress; however, other trials reported no
differences in cortisol related to weaning (Lefcourt and Elsasser, 1995) or transport
(Galyean et al., 1981) stress. According to results of the current study, the early
physiological stress during receiving indicated by serum cortisol concentrations, did not
impact the ability to respond to vaccination because calves administered RESP on-arrival
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(ACAR, DCAR) had adequate and earlier titer response to BVDV type I compared to the
delayed RESP treatments (ACDR, DCDR). Likewise, Blecha et al. (1984) reported that
elevated cortisol did not correlate with a suppressed immune response.
In conclusion, timing of vaccination did not affect ADG or health in high-risk,
newly received calves. Antibody titers to BVDV type I developed earlier when cattle
were administered a respiratory vaccine on d 0 vs. 14. Several differential WBC
measures were greater when both clostridial and respiratory vaccines were delayed. This
observation may correlate to either the occurrence of pathogenic infection or differences
in immune status. Serum cortisol concentation was greatest during the first 14 d of
receiving; however, cortisol level did not affect BVDV type I titer response and
vaccination timing did not affect cortisol level.
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Table 1. Vaccination schedule for experimental treatments
Treatment

d0

d 14

ACAR1

Alpha 72 / Express 53

Express 5

ACDR4

Alpha 7

Express 5

DCAR5

Express 5

Alpha 7 / Express 5

DCDR6

Alpha 7 / Express 5

d 28

Express 5

Express 5

1

ACAR = arrival (d 0) clostridial and respiratory vaccination.

2

Clostridium chauvoei-septicum-novyi-sordellii-perfringens types C & D bacterin-toxoid,

Boehringer-Ingelheim Vetmedica.
3

Bovine rhinotracheitis-virus diarrhea-parainfluenza3-respirtatory syncytial modified-live

virus vaccine, Boehringer-Ingelheim Vetmedica.
4

ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination.

5

DCAR = delayed clostridial, and arrival respiratory vaccination.

6

DCDR = delayed clostridial and respiratory vaccination.
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Table 2. Ingredient composition of grain supplement (as-fed basis)
Ingredient

%

Corn, cracked

73.385

Soybean meal

20

Molasses

2

Fat

1

Dicalcium phosphate

0.18

Limestone

1.8

Salt, white

1

Vitamin ADE premix1

0.1

Vitamin E2

0.05

Trace mineral premix3

0.085

Corn / Rumensin premix4

0.4

1

Contained 8,800,000 IU Vitamin A, 1,760,000 IU Vitamin D, and 1,100 IU Vitamin E

/kg.
2

Contained 44,000 IU/kg.

3

Contained 12% Zn, 8% Mn, 4% Cu, 500 mg Co, 2,000 mg I, and 600 mg Se/kg.

4

Provided 88 mg monensin (Elanco Animal Health, Indianapolis, IN)/kg of supplement.
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Table 3. Effect of clostridial and bovine respiratory disease vaccination timing on performance of newly received cattle
Contrasts1, P =
ACAR2

ACDR3

DCAR4 DCDR5

SEM

Initial wt., kg

241

239

238

238

7.7

0.42

0.51

0.62

Final wt., kg

295

290

291

289

7.3

0.36

0.27

0.60

CLOS

RESP

Interaction

ADG, kg

72
1

d 0 to 14

1.10

0.94

0.96

0.94

0.20

0.64

0.54

0.65

d 14 to 28

1.02

0.92

0.96

0.93

0.21

0.81

0.59

0.74

d 28 to 42

1.02

1.04

0.92

0.96

0.22

0.42

0.80

0.95

d 42 to 56

0.74

0.80

0.93

0.80

0.19

0.41

0.75

0.46

d 0 to 56

0.98

0.93

0.95

0.91

0.07

0.62

0.34

0.87

CLOS = main effect of timing of clostridial vaccination (d 0 vs. 14), RESP = main effect of timing of respiratory virus

vaccination, Interaction = vaccine type × timing.
2

ACAR = arrival (d 0) clostridial and respiratory vaccination.

3

ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination.

4

DCAR = delayed clostridial, and arrival respiratory vaccination.

5

DCDR = delayed clostridial and respiratory vaccination
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Table 4. Effect of clostridial and bovine respiratory disease vaccination timing on health of newly received cattle
Contrasts1, P =
ACAR2

ACDR3

DCAR4

DCDR5

Morbidity, %

71.4

60.7

75.3

69.5

9.6

Day 1st treated

6

7.3

7.3

8

Rectal temperature at treatment, ºC

40.3

40.4

40.4

Rectal temperature 48 h after treatment, ºC

39.8a

39.9a

Treated with 2nd antibiotic, %6

38.5

39.5
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Day 2nd treated
Treated with 3rd antibiotic, %6

8.8b

10b

RESP

Interaction

0.36

0.23

0.72

0.76

0.07

0.09

0.56

40.6

0.11

0.01

0.05

0.47

39.8a

39.5b

0.24

0.05

0.36

0.04

36.1

25.5

8.7

0.18

0.43

0.34

13.1a

1.3

0.07

0.002

0.05

8.7b

SEM CLOS

20.5

22.4

19.8

10.8

9.4

0.37

0.61

0.43

Dead, %

1.4

1.6

3

1.5

2.4

0.67

0.7

0.64

Chronic, %

1.5b

11.4a

6.3ab

3.2ab 4.7

0.59

0.29

0.05

a,b
1

Means within a row without a common superscript are different (P < 0.05).

CLOS = main effect of timing of clostridial vaccination (d 0 vs. 14), RESP = main effect of timing of respiratory virus

vaccination, Interaction = vaccine type × timing.
2

ACAR = arrival (d 0) clostridial and respiratory vaccination.

3

ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination.

4

DCAR = delayed clostridial, and arrival respiratory vaccination.

5

DCDR = delayed clostridial and respiratory vaccination.

6

Percentage of total population.
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Table 5. Effect of clostridial and bovine respiratory disease vaccination timing on cellular blood constituents
Contrasts1, P =

White blood cells, n  103/µL

ACAR2

ACDR3

DCAR4

DCDR5

SEM

CLOS

RESP

Interaction

10.3ab

9.9b

10.2ab

10.9a

0.37

0.08

0.62

0.06

25

26

25

22

2.6

0.08

0.51

0.18

Lymphocytes, %

61

61

63

65

2.3

0.02

0.38

0.31

Monocytes, %

10.7

10.4

9.8

9.9

0.61

0.04

0.79

0.58

Eosinophils, %

2.3

1.9

1.7

1.6

0.34

0.05

0.30

0.59

Neutrophil:lymphocyte ratio

0.55a

0.58a

0.54ab

0.45b

0.06

0.06

0.39

0.10

Red blood cells, n  106/µL

9.7

0.25

0.34

0.02

0.51

0.43

0.02

0.44

76

Neutrophils, %

Platelets, K/µL
a,b
1

516

10.3
662

10.0
589

663

55

Means within a row without a common superscript are different (P ≤ 0.05).

CLOS = main effect of timing of clostridial vaccination (d 0 vs. 14), RESP = main effect of timing of respiratory virus

vaccination, Interaction = vaccine type × timing.
2

10.4

ACAR = arrival (d 0) clostridial and respiratory vaccination.

3

ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination.

4

DCAR = delayed clostridial, and arrival respiratory vaccination.

5

DCDR = delayed clostridial and respiratory vaccination.
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ABSTRACT: Calves persistently infected (PI) with bovine viral diarrhea virus (BVDV)
are a major source of the virus; however, consequences of exposure to a PI-BVDV calf in
low-risk, single-source, preconditioned (PC) vs. high-risk, commingled, auction market
(AM) cattle may differ. Our objective was to compare treatments of PC or AM origin,
with (PI) or without (CON) exposure to a PI-BVDV calf in a 2 × 2 factorial arrangement
to evaluate effects on health and performance. Four sets (block) of crossbred PC steers (n
= 236) from 3 ranch-origins were selected randomly, weaned, dewormed, vaccinated,
tested for PI-BVDV status, and kept on the ranch for ≥ 42 d. Subsequently, PC steers
were transported to a stocker receiving unit (RU), weighed (251 ± 2 kg), bled, stratified
by d -1 BW, and assigned randomly to treatment (PCPI or PCCON) with no additional
processing. Simultaneously, 4 sets of crossbred AM calves (n = 292) were assembled
from regional auction markets for delivery to the RU ± 36 h from PC arrival. The AM
calves were weighed (245 ± 1.3 kg) and administered the same processing procedures as
PC received at their origin ranch; however, bull calves were stratified by gender and d -1
BW, castrated surgically, then AM calves were assigned randomly to treatment (AMPI or
AMCON). Treatment pens (0.45 ha) were arranged spatially so that PI did not have
fence-line contact with CON. Calves were fed identically and followed the same
antibiotic treatment protocol. Daily gain for the entire 42-d receiving trial was greater (P
< 0.001) for PC (1.2 kg) than AM (0.85 kg). There was an exposure effect (P = 0.002) on
ADG from d 28 to 42; CON gained 1.12 kg vs. 0.90 kg for PI. Morbidity rate was greater
(P < 0.001) in AM (70%) than PC (7%). Treatment with a third antibiotic occurred more
often (P = 0.04) for PI, likewise antibiotic treatment cost (P = 0.05) and the percentage of
chronic cattle (P = 0.06) were greatest for AMPI. The BVDV type 1a titer levels were
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greater on d 0 for PC (treatment × day, P < 0.001), and seroconversion to BVDV type 1a
on d 0 was 100% for PC vs. 23% in AM. Circulating leukocytes were greater (P < 0.001)
for PC on d 0, 14, and 28. The neutrophil:lymphocyte ratio was greater (P < 0.001) for
AM on d 14 and 28. Platelet count increased transiently (P < 0.001), with greater platelets
observed in AM (P < 0.001). Results suggest that PC calves gain faster and require fewer
antibiotic treatments; whereas, PI-BVDV exposure reduced gain from d 28 to 42 and
increased the number of calves requiring a third antibiotic treatment.
INTRODUCTION
Bovine respiratory disease (BRD) is a multifaceted disease involving stress,
commingling, and several viral and bacterial pathogens. Despite advances in prevention
and control, BRD remains the leading cause of feedlot morbidity and mortality
(Woolums et al., 2005) resulting in significant economic loss (Irsik et al., 2006) and
reduced animal well-being. Preconditioning is a comprehensive management practice to
prepare young calves for stocker or feedlot entry by reducing stress and improving
disease protection through pre-arrival vaccination against BRD pathogens (Cole, 1985;
Duff and Galyean, 2007). Preconditioned calves have reduced morbidity and improved
gain performance compared to high-risk calves originating from auction markets (Clark
et al., 2006; Seeger et al., 2008). Unfortunately, the estimated adoption rate of
management factors including weaning (50.2%) or respiratory vaccination (39.4%) in US
beef cow-calf operations remains low (USDA, 2010).
Bovine viral diarrhea virus (BVDV) is a major culprit in the development of BRD
either directly via acute clinical disease or through indirect effects of immunosuppression
(Welsh et al., 1995). Furthermore, calves born persistently infected (PI) with BVDV are a
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key source of BVDV transmission (Fulton et al., 2005), and although prevalence of PIBVDV calves in the feedlot is estimated to be relatively low (0.3%; Loneragan et al.,
2005), a single PI-BVDV animal has the potential to continuously expose an entire pen
and adjoining pens to the virus. Research results on effects of exposure to PI-BVDV
calves in the feedlot are conflicting; thus, the decision to invest in PI-BVDV testing of
newly received cattle remains controversial. One inconsistency among the literature is
the use of cattle with varied management and health history, and research evaluating
effects of PI-BVDV exposure in low-risk, single-source, preconditioned versus high-risk,
commingled, auction market calves is needed to determine if outcomes differ for these
different management systems.
MATERIALS AND METHODS
Cattle
Animal methods and experimental procedures were approved by the University of
Arkansas Animal Care and Use Committee.
Experimental Cattle. A total of 528 crossbred, male beef calves were used to determine
effects of weaning management and PI-BVDV exposure. Calves from 2 different
weaning management systems were utilized for this receiving trial; 1) low-risk, singlesource, preconditioned (PC) crossbred steer calves (n = 236; initial BW = 251 ± 2 kg)
arrived in 4 shipment blocks from 3 Arkansas cow-calf ranches, and 2) high-risk,
commingled, auction market (AM) crossbred bull (n = 210) and steer (n = 82) calves
(initial BW = 245 ± 1.3 kg) that arrived in 4 shipment blocks acquired from multiple
Arkansas auction markets. The 4 shipment blocks of PC calves originated from cow-calf
herds located in Izard (block 1 and 4), Hempstead (block 2), and Pulaski (block 3),
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County, AR and arrived at the University of Arkansas Agricultural Experiment Station
located near Savoy (receiving unit; RU) on October 27, 2008, January 19, August 11, or
December 6, 2009, respectively. The PC cattle were considered to be low-risk for
developing BRD because they were weaned and vaccinated against BRD pathogens ≥ 42
d prior to shipment and maintained as a single-source without commingling. Each
shipment block of AM calves were procured and assembled by an order buyer from 2 to 3
public auction markets located in Northwest or North Central, AR and arrived at the RU
on October 25, 2008, January 20, August 10, or December 5, 2009 for the 4 shipment
blocks, respectively. Order buyers were instructed to purchase AM cattle of similar BW
and phenotype as the incoming PC block. The AM cattle were considered to be high-risk
for developing BRD because they did not have known health or vaccination history and
were commingled extensively resulting in greater probability of increased stress and
exposure to BRD pathogens.
The main effects of management (AM or PC) and PI-BVDV exposure (not
exposed = CON or exposed = PI) resulted in 4 treatments in a 2 × 2 factorial
arrangement. For PC treatments, 42 to 91 d prior to trial initiation depending on block,
randomly selected steers were weaned and ear-notched to test for PI-BVDV status at a
commercial laboratory (Cattle Stats, LLC, Oklahoma City, OK) using the antigen-capture
ELISA (ACE) method (Idexx Laboratories, Inc., Westbrook, ME). Also on the day of
weaning, PC calves were administered: 1) a 5-way modified-live virus (MLV) respiratory
vaccine containing infectious bovine rhinotracheitis, bovine viral diarrhea virus type 1a
and 2a, parainfluenza3, and bovine respiratory syncytial virus isolates [Express 5,
Boehringer Ingelheim Vetmedica (BIVI), St. Joseph, MO], 2) Manheimia haemolytica-
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Pastuerella multocida bacterin-toxoid (Pulmo-guard PHM-1, BIVI), and 3) pour-on or
injectable anthelmintic (Cydectin, BIVI). Approximately 14 d later, PC calves were
administered a 7-way clostridial bacterin-toxoid (Alpha 7, BIVI) and re-vaccinated with
5-way MLV respiratory vaccine. Preconditioned calves were isolated from other cattle,
fed hay or pasture along with a supplement, and remained on their origin ranch during the
preconditioning phase until approximately d -2 when they were shipped to the RU. Upon
arrival to the RU, PC calves were maintained in an isolated holding pen with ad libitum
access to hay and water until treatment allocation on d 0. On d -1, PC calves were
weighed and returned to their isolated holding pen. The following d (d 0), PC calves were
weighed, bled via jugular venipunture into evacuated tubes (Vacutainer; BD Inc, Franklin
Lakes, NJ) to determine total and differential leukocytes (EDTA tube) and BVDV type
1a antibody titers (plain tube), stratified by d -1 BW, then assigned randomly to treatment
(PCCON or PCPI).
To coincide with PC groups, AM calves were assembled from regional markets
and delivered to the RU ± 36 h from PC arrival. Upon arrival to the RU, AM calves were
maintained in an isolated holding pen with ad libitum access to hay and water until
treatment allocation on d 0. On d -1, AM calves were weighed, identified with a unique
ear identification tag, ear notched to test for PI-BVDV status at a commercial laboratory
(Cattle Stats) using the ACE method (Idexx Laboratories), and returned to their isolated
holding pen. One AM animal in block 3 was identified as PI-BVDV and removed from
the study pen and quarantined on d 0 of the trial. On d 0, AM cattle received the same
vaccinations and processing procedures as described for PC on their origin ranch;
therefore, the first known processing for AM occurred on d 0 rather than 42 to 91 d
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previously on an origin ranch for PC. For AM calves only, re-vaccination of the 5-way
MLV respiratory vaccine (Express 5, BIVI) occurred on d 14 in addition to
administration of a 7-way clostridial bacterin-toxoid (Alpha 7, BIVI). Additionally on d
0, bull calves were castrated surgically, stratified by gender and d -1 BW, then AM calves
were assigned randomly to treatment (AMCON or AMPI). Cattle were moved to their
randomly assigned 0.45-ha pens and provided 0.91 kg/d (as-fed basis) of a receiving
supplement (Table 1; 15.3% CP, DM basis) and ad libitum access to bermudagrass hay
(13.1% CP, 64% NDF, 42% ADF, DM basis) and water. Supplement offered was stepwise increased to a maximum of 2.73 kg/d as each pen completely consumed the
supplement offered for 2 consecutive d.
All BW measurements were obtained individually without withholding feed or
water on 2 consecutive days at the beginning (d -1 and 0) and end (d 42 and 43) of the
receiving trial using a chute equipped with electronic load cells to determine overall
differences in gain performance. To determine interim differences in gain performance,
individual BW was recorded at 14-d intervals during the trial (d 14 and 28). Furthermore,
calves were bled on d 14 and 28 to determine interim total and differential leukocytes and
BVDV type 1a titers. Anticoagulated whole blood was collected from each animal into
EDTA tubes, kept refrigerated (5° C), and analyzed within 24 h to determine percentage
and concentrations (n cells/µL) of total and differential (lymphocytes, neutrophils,
monocytes, eosinophils, and basophils) peripheral blood leukocytes (PBL), platelets, red
blood cells, hemoglobin, and hematocrit with an automated hemacytometer (Cell-Dyn
3500 system, Abbott Laboratories, Abbott Park, IL) standardized for analysis of bovine
blood.
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Blood collected from each animal in plain evacuated tubes was centrifuged at
2,100 × g for 20 min at 20° C, and serum was decanted into duplicate aliquots and stored
frozen at -20° C. Subsequently, 5 sample aliquots were selected randomly from each
treatment pen from d 0 and 28 and shipped on ice via overnight parcel service to the Iowa
State University Veterinary Diagnostic Laboratory (ISUVDL, Ames, IA) for
determination of serum neutralizing antibody titers against BVDV type 1a (Singer strain)
using the virus neutralization (VN) assay. A second set of serum aliquot samples were
pooled within day (0 and 28 only) and treatment pen, and shipped on ice via overnight
parcel service to the Texas Veterinary Medical Diagnostic Laboratory – Amarillo
(TVMDL, Amarillo, TX) for determination of serum neutralizing antibody titers against
BVDV type 1a (strain NADL), 1b (strain TGAC), and 2a (strain 125). All titers were
reported as the reciprocal of the greatest dilution of serum to provide complete protection
of cells. For the ISUVDL analysis, the least dilution of serum tested was 1:2, whereas the
greatest dilution tested was 1:4096. Serum that did not provide complete protection at the
1:2 level was reported as < 2 and was considered negative for seroconversion to BVDV
type 1a. Samples with a reported serum neutralization value of ≥ 2 were considered
positive for seroconversion to BVDV type 1a. For the TVMDL analysis, the least dilution
of serum tested was 1:4, whereas the greatest dilution tested was 1:1024. For both titer
level analyses, the reported values were log2 transformed prior to statistical analysis.
Persistently Infected Cattle. Two groups of calves that had been previously ear-notched,
tested at a commercial laboratory (Cattle Stats), and identified as PI-BVDV according to
ACE method were acquired from a stocker cattle operation in Washington County, OK to
be utilized as PI-BVDV exposure sources. Upon arrival to the RU, each PI-BVDV calf
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was ear-notched a second time, and samples were shipped via overnight parcel service to
a different laboratory [Oklahoma Animal Disease Diagnostic Lab, Stillwater, OK or
USDA, ARS, National Animal Disease Center (NADC), Ames, IA] for rapid reaffirmation of positive PI-BVDV status using the same ACE procedure. Group 1 (n = 10)
was assembled prior to trial initiation and utilized for shipment block 1 and 2; whereas,
group 2 (n = 9) was assembled prior to beginning block 3, and utilized for block 3 and 4
of the trial. Depending on block, 4 to 8 PI-BVDV challenge calves were assigned
randomly to a PI-designated pen. An appropriate number of PI-BVDV calves were
assembled for each group to allow for available alternates if an originally designated PIBVDV animal died. Each PI-BVDV calf that died during the trial (Group 1, n = 2; Group
2, n = 1) was replaced immediately with a confirmed PI-positive alternate. Additionally,
anticoagulated blood was collected from each PI-BVDV challenge animal and shipped on
ice via overnight parcel service to NADC for subsequent differentiation of BVDV
subgenotype strain using virus isolation of buffy coat cells and reverse-transcriptase PCR
analysis previously described by Ridpath and Bolin (1998). The subgenotype strain of the
2 PI-positive alternates in Group 1 was unknown. Of the PI-BVDV calves acquired for
use as exposure sources in the current study and subgenotype confirmed, 94.7% (18 of
19) were identified as subgenotype 1b. One PI-BVDV animal from Group 2 was
identified as subgenotype 1a, and the pen in which this animal was assigned was removed
from all statistical analyses. It is important to note that BVDV 1b, the subgenotype strain
in which the PI-BVDV calves used in this experiment were identified, is the predominant
BVDV subgenotype strain isolated from cattle in the US (Fulton et al., 2002; Ridpath et
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al., 2010); however, currently no commercial licensed MLV respiratory vaccine in the
US contains a BVDV 1b isolate.
Pen Assignment and Arrangement
To avoid unwanted PI-BVDV fence-line contact with CON, 0.45-ha mixed-grass
receiving pens were arranged spatially prior to treatment allocation (Figure 1). Pens
measured 30.5 × 152 m, contained 5 m of feed bunk-line and a fence-line water source
shared with an adjacent pen of the same treatment. Furthermore, the treatment pens were
configured so that unlike treatment pens were separated by either a 3 m drovers, or 5 m
feed alley. Within management group, calves were stratified by gender (AM only) and d 1 BW, then assigned randomly to 1 of 2 or 1 of 4 PI or CON pens depending on block (8
to 11 calves/pen) resulting in total experimental unit (pen) replication of 14, 14, 12, and
11 for AMCON, AMPI, PCCON, and PCPI, respectively. For PI treatments, a PI-BVDV
type 1b challenge animal was assigned randomly to each PI-designated treatment pen
such that pens within block had an equivalent number of cattle. During all weighing and
BRD evaluation procedures, CON treatments were evaluated first, followed by PI
treatments to avoid unwanted CON contact with PI challenge animals or experimental
cattle in the PI treatments, and to reduce possible exposure to fomites contaminated with
secretory fluid or fecal material containing BVDV.
Evaluation and Treatment of BRD
Calves were observed daily for clinical signs of respiratory illness (depression,
nasal discharge, ocular discharge, cough, gaunt appearance) by 2 experiment station
personnel with a combined 35-yr experience evaluating cattle with BRD. If ≥ 2 visual
signs existed, calves were brought to the restraining chute, weighed, and rectal
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temperature was recorded via a digital thermometer (GLA Agricultural Electronics; San
Luis Obispo, CA; readability = ± 0.1°C). If rectal temperature was ≥ 40°C, cattle were
considered morbid, administered antibiotic therapy with enrofloxacin (Baytril, Bayer
Animal Health, Shawnee Mission, KS) at a dosage rate of 10 mg/kg of BW, and
immediately returned to their home pen. A 48 h post-treatment interval (PTI) was
implemented following administration of enrofloxacin, and a second temperature was
recorded upon expiration of the initial antibiotic PTI. If the second temperature was ≥
40°C, a second antibiotic treatment with florfenicol (Nuflor, Schering-Plough Animal
Health, Summit, NJ) was administered at a dosage rate of 40 mg/kg of BW. A 48 h PTI
was also implemented for cattle administered florfenicol, and rectal temperature was
evaluated upon expiration of the second antibiotic PTI. If the temperature was ≥ 40°C, a
third and final antibiotic treatment with ceftiofur HCl (Excenel RTU, Pfizer Animal
Health, New York, NY) was administered at a dosage rate of 2.2 mg/kg of BW and
repeated for 2 consecutive days following the initial injection of ceftiofur HCl. If at any
time rectal temperature was < 40°C, the animal was left untreated and returned
immediately to the treatment pen until further symptoms warranted re-examination.
Treatment data were recorded for individual animal including treatment date, rectal
temperature, and the amount (mL) of each antibiotic administered.
Calculations and Statistical Analyses
Calculations. Average antibiotic treatment cost was calculated using a fixed cost
of $0.65/mL for enrofloxacin, $0.47/mL for florfenicol, and $0.65/mL for ceftiofur HCl.
To determine percentage chronic, an animal was classified as chronically ill if 3 antibiotic
treatments were administered coupled with ≤ 0.45 kg ADG for the entire 42-d trial. The
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BRD relapse rate was determined by dividing the number of calves within each treatment
requiring a 2nd antibiotic by the total number of calves in each treatment treated for BRD.
Statistical Analyses. Performance and morbidity data were analyzed as a
randomized complete block design using the MIXED procedure of SAS (SAS Inst., Inc.,
Cary, N.C.). Pen was considered the experimental unit. The class statement included
block (date of arrival), treatment and replicate. Block was considered a random effect in
the statistical model. Single degree of freedom orthogonal contrasts evaluating effects of
management (PC or AM), exposure (PI or CON), and their interaction were used. If the
interaction was significant (P ≤ 0.10), treatment means were separated with a t-test using
the PDIFF option in SAS. For main effects of management and exposure, a P-value ≤
0.05 was considered statistically significant. For repeated measures data, the model
included treatment, day, and treatment × day. Block, treatment, day and pen were used in
the class statement. Block was the random variable, pen within block was the subject, and
the repeated statement was day. The covariance model structure used was AR(1).
Contrasts for the repeated measures data included management, exposure, management ×
exposure interaction, and the linear and quadratic effect of day.
RESULTS AND DISCUSSION
Animal Performance
No treatment interactions (P ≥ 0.10) were observed for animal performance;
therefore, only main effects of management and exposure are presented (Table 2). Singlesource PC calves had greater (P < 0.001) ADG than commingled AM calves from d 0 to
14 (1.65 vs. 0.66 kg/d), d 0 to 28 (1.28 vs. 0.77 kg/d) and d 0 to 42 (1.20 vs. 0.85 kg/d).
Results suggest clearly that prior vaccination against BRD pathogens and weaning
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management that reduces psychological and physiological stress of single-source beef
calves results in greater gain performance during a 42-d stocker receiving period. Step et
al. (2008) evaluated effects of health and performance in beef calves from a single-source
ranch (RANCH) either weaned and immediately shipped to a feedlot (WEAN), weaned
and kept on the ranch for 45 d before shipment without receiving any vaccinations
(WEAN45), weaned and kept on the ranch for 45 d before shipment and vaccinated with
a MLV respiratory vaccine (WEANVAC45), procured and assembled through several
auction markets (MARKET), or a commingled group (COMM) containing a portion of
RANCH and MARKET origin cattle. Regardless of weaning or vaccination status, calves
originating from RANCH tended to have greater ADG than COMM or MARKET calves
for the 42-d receiving period. In a trial conducted by Clark et al. (2006), low-risk
preconditioned calves had greater ADG during the finishing period than high-risk auction
market calves of unknown history; however, no differences in performance were
observed during the 28-d receiving period. Seeger et al. (2008) observed that auction
market steers of unknown origin or health history gained 0.18 kg/d less during a finishing
period than weaned beef calves receiving a health protocol on their origin ranch prior to
marketing; however, an unequal number of calves testing positive for PI-BVDV
remained in their treatment pens during the trial which may have confounded results.
Research conducted by Pritchard and Mendez (1990) suggests that non-preconditioned
calves may fully compensate for initial performance loss by the end of the feeding period;
however, the non-preconditioned cattle used in that experiment would be considered lowrisk because they were maintained as a single-source and were not subjected to typical
stressors associated with the auction market system. Further research with careful
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consideration of experimental design is needed to determine differences in health,
performance and the economic value of single-source PC vs. commingled AM cattle.
Exposure to a PI-BVDV calf in the pen resulted in inconsistent, yet interesting
differences in performance during the 42-d receiving period. From d 0 to 28, PI-BVDV
exposure tended (P = 0.10) to increase performance with PI-exposed calves averaging
1.06 kg/d versus 1.00 kg/d for non-PI exposed calves. Conversely, Elam et al. (2008)
observed a tendency for PI-BVDV exposed cattle to gain less from d 0 to 28, although
overall ADG was not affected by PI-BVDV exposure in that study. During the final
interim period (d 28 to 42) of our receiving trial, PI-BVDV exposure resulted in a 0.22
kg/d decrease (P = 0.003) in ADG suggesting that negative performance consequences of
low-virulence PI-BVDV exposure in newly received beef calves may be delayed several
weeks. The performance loss observed from d 28 to 42 agrees with the findings of
Hessman et al. (2009), in which cattle directly exposed to a PI-BVDV animal gained 0.15
kg/d less than non-exposed cattle during a 66 d feedlot starter period. Reasons for our
observation of a tendency for an increase, followed by a significant decrease in
performance from PI-BVDV exposure are unknown; however, complex epidemiological
and behavioral factors may have contributed. During the initial weeks of our study, PIBVDV calves may have unintentionally served as a trainer animal because they had been
previously acclimated to the RU facilities. In a series of 4 trials, Loerch and Fluharty
(2000) observed increases in eating behavior and variable ADG for newly received calves
with a trainer cow present in the pen during the initial 14 d; however, overall (28-d)
differences in growth were undetectable in 3 of 4 trials. Another consideration is that
abbreviated exposure to a low-virulent BVDV strain from PI-calves could simply mimic

91

an unattenuated autogenous vaccination (Elam et al., 2008) resulting in undetectable, or
slight performance effects during the initial weeks of PI challenge. However, as the trial
progressed and PI-BVDV exposure continued, an additive effect on host immune activity
may have resulted in the performance loss observed from d 28 to 42 because repeated
immune stimulation results in nutrients being preferentially utilized for immune and
homeostatic pathways rather than tissue deposition (Klasing and Korver, 1997; Spurlock,
1997). Therefore, our ADG results would indicate that there may be a substantial
metabolic cost associated with continuous exposure to a PI animal shedding a lowvirulence BVDV strain and the resulting performance loss is not immediate but rather
several weeks subsequent when nutrients utilized for humoral and cell-mediated
immunity associated with repeated BVDV exposure presumably reach a threshold level.
Because BW measurements were not recorded beyond the 42-d receiving period, the
duration of performance loss and whether there was compensatory gain during the
finishing phase is unknown. Performance from d 0 to 42 was not affected (P = 0.29) by
PI-BVDV exposure; however, the degree to which the slight increase in gain for PIexposed calves from d 0 to 28 followed by the reduction in gain of PI-exposed calves for
the final weigh period (d 28 to 42) would have confounded the d 0 to 42 ADG results
should be considered. Research evaluating PI-BVDV exposure effects on performance is
both limited and conflicting; therefore, further efforts with careful consideration of
management and health history of experimental cattle, differences in the virulence and
subgenotype strain of PI-BVDV challenge animals, and epidemiological factors are
needed to determine effects of PI-BVDV exposure on performance throughout the
various stages of the beef production system. Furthermore, a better understanding of the
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metabolic cost associated with physiological and immunological products in response to
stress and pathogen challenge is needed.
Animal Health
The BRD morbidity rate was markedly greater (P < 0.001) for AM than PC with
70.4 and 6.7% of calves, respectively requiring treatment for BRD (Table 3).
Furthermore, a greater number of AM calves required treatment with a second (P <
0.001), and third (P = 0.001) antibiotic. Our BRD morbidity results were similar to Clark
et al. (2006) in which BRD morbidity rates were 64.4 and 2.0% in steers considered
either high- or low-risk for developing signs of BRD, respectively. Other studies
(Macartney et al., 2003; Seeger et al., 2008), reported that calves of unknown health
history had greater morbidity compared with those administered health protocols prior to
marketing. Roeber et al. (2001) observed that cattle originating from preconditioning
programs had fewer hospital visits than cattle originating from auction markets. In the
Step et al. (2008) study described previously, morbidity was 11.1% for RANCH and
41.9% for MARKET calves. Among the 3 RANCH-origin treatments, those weaned and
shipped directly to the feedlot (WEAN) had greater morbidity compared to WEAN45 and
WEANVAC45, but vaccination with a MLV respiratory vaccine at weaning did not
reduce morbidity during the receiving period among the 2 treatments held on the origin
ranch for 45 d. Their results would provide evidence that weaning management intended
to reduce physiological stress had a more profound effect on subsequent morbidity than
did administration of a MLV respiratory vaccine.
In the present study, antibiotic treatment cost during the 42-d receiving period
was markedly greater (P < 0.001) for AM calves ($20.52/animal) than PC ($2.48/animal).
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Moreover, the percentage of chronically ill cattle was increased (P = 0.03) for AM. The
large difference observed for health parameters among the 2 cattle management sources,
supported by other peer-reviewed research, would suggest clearly that single-source PC
calves have fewer BRD-related health problems, improved animal well-being, and
reduced antibiotic usage compared to commingled AM calves of unknown management
and health history.
The overall BRD morbidity rate was not affected (P = 0.50) by PI-BVDV
exposure. However, administration of a third antibiotic occurred more often (P = 0.04)
with PI exposure and a treatment interaction (P = 0.06) was observed for the percentage
of chronically ill animals; AMPI had the greatest number of chronically ill calves (7.6%),
AMCON was intermediate (1.1%), and PCCON and PCPI were least (0.4 and 0.3%,
respectively). A trend (P = 0.10) was observed for PI-exposed calves having an increased
antibiotic treatment cost which averaged $12.59 and $10.40/animal for PI and CON
treatments, respectively. Within AM calves only, PI exposure resulted in an antibiotic
treatment cost of $4.06/animal more than CON; this numerical difference being similar to
our PI-BVDV testing cost ($4.25/sample including next day parcel service fees). Our
results would agree with a large-scale study using high-risk calves of unknown history
(Hessman et al., 2009) in that overall morbidity was not different for direct PI-exposed or
unexposed groups; however, percentage of first relapse, chronic illness and fatalities were
all greater for the direct PI-exposed groups. In that trial, treatment cost/animal was not
statistically different (P = 0.24), but a numerical increase of $1.19/animal was observed
for direct PI-exposed groups. Loneragan et al. (2005) reported cattle exposed to a PIBVDV animal had a 43% greater risk of initial BRD treatment and in cattle that became
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ill, those exposed to a PI-BVDV animal were administered more antibiotic treatments
than non-exposed groups (1.76 vs. 1.46). Conversely, others have observed no
differences in BRD health among PI- and non-PI-exposed pens (Booker et al., 2008;
Elam et al., 2008); whereas, O’Conner et al. (2005) observed that disease prevalence was
reduced in pens containing single-source cattle with a PI-BVDV calf present. Reasons for
conflicting observations among the literature may be explained two-fold: 1) previous
management and health history of cattle used within or among scientific experiments is
varied; thus, susceptibility of experimental calves to PI-BVDV exposure may differ, 2)
the virulence of BVDV strain and amount of BVDV particles shed by PI challenge
animals varies among or within experiments.
Our observation of negative BRD-related health outcomes being most prevalent
for AMPI, with few animal health differences observed among PCPI and PCCON
treatments suggests that previous management and vaccination against BVDV and other
respiratory pathogens may enhance protection against PI-BVDV challenge. Therefore,
the degree to which PI-BVDV exposure affects economically important traits related to
BRD morbidity in a stocker program or feedlot is influenced by previous management
and health history in newly received calves, and the decision to test and remove PIBVDV animals from an isolated group of calves may be based in part upon the perceived
BRD risk level.
BVDV Antibody Titers
Individual Analysis. For individual samples analyzed at ISUVDL, d 0 BVDV
type 1a (Singer strain) antibody titers were profoundly increased (treatment × day, P <
0.001; Figure 2) for PC, and seroconversion to BVDV type 1a on d 0 was 100 and 23%

95

for PC and AM, respectively. The difference in antibody titers against BVDV type 1a on
d 0 would indicate that AM calves were relatively naïve and PC calves had greater
humoral immunity against either acute BVDV infection or PI-BVDV challenge.
Serological data from previous studies indicate that greater serum antibody titers against
BVDV upon arrival at the feedlot correspond with a subsequent reduction in risk for
clinical BRD (Martin et al., 1999; O’Connor et al., 2001). Bolin and Ridpath (1995)
observed that BVDV challenged calves with greater titer levels of passively acquired
viral neutralizing antibody in serum had reduced duration and severity of clinical disease.
In another trial (Fulton et al., 2006), vaccination with 2 doses of MLV respiratory vaccine
containing both BVDV type 1a and 2a isolates provided protection against viremia in
calves exposed to PI-BVDV type 2a challenge animals during a 35-d observation period.
However, it has also been suggested that pre-existing antibodies, particularly those
heterologous to the subgenotype strain shed by PI challenge animals may not be
sufficient to provide complete protection (Fulton et al., 2005).
By d 28, BVDV type 1a titers levels were similar for all treatments; however, the
incidence of first, second, and third BRD episode for all calves was d 2.3, 5, and 8.8,
respectively, with few BRD episodes occurring after d 28. It should be considered that
AM received identical vaccinations and processing procedures as PC, only the timing of
administration differed, suggesting that MLV respiratory vaccination prior to marketassociated stress and pathogen exposure is critical to achieve sufficient antibody titer
concentrations before the initial 14 d of receiving when BRD is most often prevalent.
Furthermore, arrival MLV respiratory vaccination of known single-source, recently
vaccinated PC calves may be redundant because in our experiment PC calves were not re-
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vaccinated on arrival, yet 100% were seropositive for BVDV type 1a on d 0 and BRD
morbidity for PC calves during the 42-d receiving period was low (7.2 %).
Pooled Analysis. To provide field study insight on cross-reactivity of BVDV
strains after PI-BVDV type 1b exposure, serum samples (pooled within treatment pen)
were tested for titers against BVDV type 1a (NADL strain), BVDV type 1b (TGAC
strain), and BVDV type 2a (125 strain) at TVMDL-Amarillo. A management effect (P <
0.001) was observed for BVDV type 1a (Figure 3), BVDV type 1b (Figure 4), and
BVDV type 2a (Figure 5) titers; thus, on d 0 PC had markedly greater titers compared to
AM for all 3 BVDV subgenotypes tested. Furthermore, interactions were observed for
BVDV 1b (P = 0.08) and BVDV type 2a (P = 0.01) antibody titers. For both
subgenotypes, PCPI, which had not been vaccinated on d 0 of the trial, had greater serum
antibodies on d 28 which suggests that continuous PI-BVDV challenge stimulated the
humoral immune response in PC calves. A titer increase on d 28 was not observed for
AMPI; however, the MLV respiratory vaccine administered on d 0 and 14 to AM calves,
which contained BVDV 1a and 2a isolates, likely confounded the titer response to PIBVDV exposure. Because no interaction or exposure effect was observed for BVDV type
1a, yet BVDV 1b titers were greatest on d 28 for PCPI calves exposed to PI-BVDV type
1b challenge, our data would provide limited evidence that some difference in crossprotection existed. Burciaga-Robles et al. (2010) reported increased antibody titers to
BVDV type 1b (TGAC 8HB), but not type 1a (Singer strain) or 2a (125-C) when steers
were exposed to 2 PI-BVDV type 1b challenge animals for 72 h and Ridpath et al. (2010)
reported that the ratio of virus cross-neutralization among BVDV type 1a and 1b
subgenotype strains is 36%. Therefore, increases in serum antibody titers associated with
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PI-BVDV exposure may be dependent upon the specific subgenotype strain of PI-BVDV
challenge.
Hematology
Effects of management (P < 0.001; Table 4) and linear effects of day (P < 0.001)
were observed for the total concentration of PBL in whole blood samples. Total PBL
averaged 10.9 and 8.6 × 103/µL for PC and AM treatments, respectively, and PBL
concentration increased overall with time. Treatment × day interactions were observed
for percentage neutrophils (P = 0.002), percentage lymphocytes (P = 0.004), lymphocyte
count (P = 0.02), and neutophil:lymphocyte ratio (P < 0.001; Figure 6). Data indicate that
neutrophils increased for AM, but not for PC calves (management effect, P < 0.001);
whereas, lymphocyte count and percentage increased for PC, but remained constant for
AM as the study progressed (management effect, P < 0.001). This resulted in the overall
neutrophil:lymphocyte ratio (N:L) being greater (P < 0.001) for AM calves; as the trial
progressed, N:L increased for AM, but decreased for PC (treatment × day, P < 0.001).
Other studies (Kegley et al., 1997; Ishizaki and Kariya, 2010) report transient increases in
N:L for cattle experiencing transport stress; however, an additive effect from additional
stressors also shown to increase N:L such as weaning (Hickey et al., 2003) and
commingling (McGlone et al., 1993) may explain the extended duration of increased N:L
observed for the AM calves in our study. Microbial pathogen challenge can also impact
total and differential PBL in cattle; challenge with BVDV, Manheimia haemolytica, or
both were shown to affect several PBL measurements (Burciaga-Robles et al., 2010).
Further research is needed to determine the capability of PBL analysis to indicate stress
and disease status of cattle.
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A treatment × day interaction was observed for concentrations of red blood cells
(P < 0.001), hemoglobin (P < 0.001), platelets (P = 0.03) and percentage hematocrit (P <
0.001; Figure 7). A tendency for an exposure effect occurred for red blood cells (P =
0.10), hemoglobin (P = 0.07), and hematocrit (P = 0.09); mean values for each of these
measurements were greater for PI-exposed calves. A management effect (P < 0.001) was
observed for platelet concentration; AM had greater platelets on d 14 and 28, which may
indicate the presence of increased inflammation or a more stimulated cell-mediated
immune response because platelets are an abundant source of CD154, a signaling
molecule for T- and B-cell activation (Sowa et al., 2009). Furthermore, there was
anecdotal evidence suggesting the association among platelet level and cell-mediated
immune stimulation because the majority of clinical BRD symptoms occurred by d 14,
which correlates with peak platelet levels observed on d 14.
In conclusion, differences in the subgenotype strain, virulence, and amount of
BVDV particles shed by PI challenge calves, coupled with the vaccination and
management history of a particular pen or group are key aspects that determine
susceptibility and consequences of PI-BVDV exposure to non-PI cohorts. Study to study
variation of these factors may explain the conflicting health and performance results in
the published literature. Additional research considering these issues is needed to
determine if PI-BVDV testing and removal in newly received calves is economically
justified. Our results would suggest that costs incurred for labor, shipping, laboratory
testing of ear-notch samples, and removal of animals identified as PI-BVDV may not
overcome production losses for single-source, PC calves during the receiving period.
Nevertheless, high-risk, commingled, AM cattle that are naïve and experiencing
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physiological stress and immune modulation may warrant testing and removal of PIBVDV animals; however, additional research from both large-scale and randomized
controlled trials is needed. Continuous exposure to PI-BVDV challenge during the 42-d
receiving period reduced gain from d 28 to 42; however, it was not known the duration of
performance loss and whether compensatory gain occurred after the 42-d receiving
period ended.
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Table 1. Ingredient composition of supplement (%, as-fed basis) for newly received
cattle
Maximum feeding rate
1.82 kg/d

2.73 kg/d

Ingredient
Corn, cracked

68.365

68.595

Dried distillers grain with solubles

26

26

Salt, white

1

1

Limestone

2

2

Molasses

2

2

Vitamin A, D, E, premix1

0.15

0.09

Trace mineral premix2

0.085

0.055

Corn/Rumensin premix3

0.4

0.26

1

Contained 5,896,000 IU vitamin A, 1,179,200 IU vitamin D, and 15,257 IU vitamin

E/kg.
2

Trace mineral premix contained 12% Zn, 8% Mn, 4% Cu, 500 mg of Co, 2,000 mg of I,

and 600 mg Se/kg.
3

Provided 88 mg of monensin (Elanco Animal Health, Indianapolis, IN)/kg of

supplement.
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Table 2. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on performance of
newly received beef calves
Auction market
Item

Control

Contrast,1 P =

Preconditioned

PI-BVDV

Control

PI-BVDV

SEM

Management

Exposure

Interaction

BW, kg

105

Initial

249

248

250

249

9.26

0.36

0.43

0.58

d 14

257

258

273

273

9.75

0.0001

0.60

0.72

d 28

270

270

285

286

9.09

0.0001

0.57

0.73

Final

286

283

301

299

7.51

0.0001

0.19

0.71

ADG, kg
d 0 to 14

0.54

0.77

1.64

1.66

0.19

0.0001

0.16

0.20

d 0 to 28

0.74

0.81

1.25

1.32

0.15

0.0001

0.10

0.97

d 28 to 42

1.10

0.89

1.13

0.90

0.15

0.77

0.003

0.87

d 0 to 42
1

0.86

0.84

1.21

1.18

0.10

0.0001

0.29

0.99

Management = main effect of weaning management (auction market vs. preconditioned); Exposure = main effect of PI-BVDV

challenge (control vs. persistently infected bovine viral diarrhea virus challenge); Interaction = management × exposure.

106

Table 3. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on health of newly received beef
calves
Auction market
Item

Control

PI-BVDV

Contrasts,1 P =

Preconditioned
Control

PI-BVDV

SEM Management

Exposure

Interaction

Morbidity, %

67.2

73.7

7.7

5.7

4.30

0.0001

0.50

0.22

Treated once, %

33.1

30.2

3.2

0

4.00

0.0001

0.40

0.96

3.0

2.7

2.5

0.9

1.47

0.23

0.33

0.49

26.0

25.9

1.1

0.6

3.78

0.0001

0.94

0.95

Day of second treatment

7.3

6.2

4.0

2.6

1.65

0.007

0.30

0.92

Treated thrice, %

8.0

17.5

3.2

4.9

3.08

0.002

0.04

0.15

Day of third treatment

10.7

11.1

7.1

6.1

3.07

0.08

0.90

0.76

Relapse2, %

50.6

58.5

60.3

20.78

0.07

0.09

0.26

2.26

0.03

0.07

0.06

Day of first treatment
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Treated twice, %

Chronic3, %

1.1b

7.6a

0.4b

100
0.3b

Medication cost, $/calf
a,b
1

18.49

22.55

2.31

2.65

2.01

0.0001

0.10

0.16

Means within a row without a common superscript are different (P < 0.05).

Management = main effect of weaning management (auction market vs. preconditioned); Exposure = main effect of PI-BVDV

challenge (control vs. persistently infected bovine viral diarrhea virus challenge); Interaction = management × exposure.
2

Relapse percentage calculated by dividing the number of calves within each treatment requiring a second antibiotic by the total

number of calves in each treatment treated for BRD.
3

Cattle were classified as chronic if 3 antibiotic treatments were administered and ADG ≤ 0.45 kg for the entire 42-d trial.
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Table 4. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on hematology of newly
received beef calves
Auction market
Item
Total leukocytes, n × 103/μL
Neutrophils, n/μL
Neutrophils, %
109

Lymphocytes, n/μL
Lymphocytes, %
Neutrophil:lymphocyte
Monocytes, n/μL
Monocytes, %
Eosinophils, n/μL

Control
8.53
2,344
28.4
4,886
55.3
0.64
1,071
13.3
141

PI-BVDV
8.68
2,407
28.5
5,040
56.1
0.67
1,021
12.8
120

Contrasts,1 P =

Preconditioned
Control
10.77
2,599
26.1
6,784
60.2
0.53
1,100
10.8
178

PI-BVDV

SEM

Management

Exposure

Interaction

10.98

0.39

0.0001

0.62

0.94

0.41

0.66

0.39

0.002

0.27

0.24

0.0001

0.35

0.64

1.60

0.0001

0.18

0.38

0.04

0.0001

0.47

0.13

0.75

0.32

0.87

0.0001

0.28

0.89

0.03

0.75

0.52

2,403
23.4
7,255
63.6
0.45
1,030
10.1
185

161
1.22
358

64.2
0.57
24.0

Eosinophils, %

1.7

1.4

1.7

1.8

0.23

0.38

0.58

0.39

Red blood cells, n × 106/μL

9.60

9.86

9.75

9.92

0.14

0.40

0.10

0.71

Hemoglobin, g/100 mL

11.64

11.95

11.88

12.08

0.15

0.18

0.07

0.69

Hematocrit, %

34.9

35.9

35.5

36.0

0.44

0.36

0.09

0.59

555.6

542.1

459.3

461.6

0.002

0.84

0.77

Platelets, n × 103/μL
1

29.0

Management = main effect of weaning management (auction market vs. preconditioned); Exposure = main effect of PI-BVDV

110

challenge (control vs. persistently infected bovine viral diarrhea virus challenge); Interaction = management × exposure.

Feed Alley

Feed Alley

Drover’s Alley
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Figure 1. Example (not to scale) of spatial treatment arrangement of newly received calves located at UA Experiment Station (RU).
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Figure 2. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum antibody concentrations against bovine viral diarrhea virus
(BVDV) type 1a (Singer strain) using individual animal analysis. Effect of treatment ×
day (P < 0.001), day (P < 0.001), and management (P < 0.001). Means within a day
without a common superscript differ (P ≤ 0.05). AMCON = auction market, control;
AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON =
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV
exposure.
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Figure 3. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum antibody concentrations against bovine viral diarrhea virus
(BVDV) type 1a (NADL strain) using pooled analysis. Effect of treatment × day (P <
0.001), day (P < 0.001), and management (P < 0.001). Means within a day without a
common superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI =
auction market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned,
control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 4. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum antibody concentrations against bovine viral diarrhea virus
(BVDV) type 1b using pooled analysis. Effect of treatment × day (P < 0.001), day (P <
0.001), and management (P < 0.001). A tendency (P = 0.11) was observed for exposure
effect. Means within a day without a common superscript differ (P ≤ 0.05). AMCON =
auction market, control; AMPI = auction market, exposed to continuous PI-BVDV
challenge; PCCON = preconditioned, control; PCPI = preconditioned, exposed to
continuous PI-BVDV exposure.
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Figure 5. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum antibody concentrations against bovine viral diarrhea virus
(BVDV) type 2 using pooled analysis. Effect of treatment × day (P < 0.001), day (P <
0.001), and management (P < 0.001). Means within a day without a common superscript
differ (P ≤ 0.05). AMCON = auction market, control; AMPI = auction market, exposed
to continuous PI-BVDV challenge; PCCON = preconditioned, control; PCPI =
preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 6. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on hematology of newly
received beef calves. AMCON = auction market, control; AMPI = auction market, exposed to continuous PI-BVDV challenge;
PCCON = preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.

117
Figure 7. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on hematology of newly
received beef calves. AMCON = auction market, control; AMPI = auction market, exposed to continuous PI-BVDV challenge;
PCCON = preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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ABSTRACT: Calves persistently infected (PI) with bovine viral diarrhea virus (BVDV)
are a major transmission source of the virus; however, physiological alterations resulting
from exposure to this natural BVDV challenge model are not well understood, and the
magnitude may differ for single-source, preconditioned (PC) vs. commingled, auction
market (AM) cattle. Our objective was to compare treatments of PC or AM origin, with
(PI) or without (CON) 14-d continuous exposure to a PI-BVDV calf in a 2 × 2 factorial
arrangement to evaluate effects on total and differential leukocyte concentrations, serum
TNF-α, IFN-γ, IL-4, IL-6 concentrations and rectal temperature (RT). Crossbred PC
steers (n = 27) from a single ranch-origin were selected randomly, weaned, dewormed,
vaccinated, tested for PI-BVDV status, and kept on the ranch for 61 d. Subsequently, PC
steers were transported to a stocker receiving unit (RU), weighed (282 ± 1.6 kg),
stratified by d -1 BW, and assigned randomly to treatment (PCPI or PCCON) with no
additional processing. Simultaneously, a group of crossbred AM calves (n = 27) were
assembled from regional auction markets and delivered to the RU 24 h before PC arrival.
The AM calves were weighed (268 ± 2.3 kg) and administered the same processing
procedures as PC received at their origin ranch; however, bull calves were stratified by
gender and d -1 BW, castrated surgically, then AM calves were assigned randomly to
treatment (AMPI or AMCON). Treatment pens (50 m × 15 m) were arranged spatially so
that PI did not have fence-line contact with CON. For cytokine and hemagram analyses,
whole blood or serum was analyzed on d 0, 1, 3, 5 (hemagram only), 7, and 14. In AM
calves, RT increased (P < 0.001) sharply on d 1, and remained elevated until d 7.
Exposure to PI-BVDV challenge decreased (P = 0.01) the percentage of neutrophils, and
increased (P = 0.02) percentage lymphocytes resulting in a tendency (P = 0.07) for a
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decreased neutrophil:lymphocyte ratio. Concentrations of TNF-α tended to increase (P =
0.09) for PI-BVDV exposed calves. Interferon-γ concentrations on d 7 and 14, IL-6
concentrations on d 14, and platelets on d 7 were greatest for AMPI (P ≤ 0.05). Overall,
these results indicate effects of weaning management and PI-BVDV exposure in altering
the immune status of newly received calves, and these effects may be additive because
physiological alterations resulting from stress, pathogens, or both were greatest for
AMPI.
INTRODUCTION
Bovine respiratory disease (BRD) is a multifaceted syndrome involving
physiological stress, commingling, and several viral and bacterial pathogens.
Physiological alterations in response to individual stressors such as weaning (Hickey et
al., 2003; Carroll et al., 2009), transportation (Blecha et al., 1984; Buckham Sporer et al.,
2008; Stanger et al., 2005), castration (Fisher et al., 1997) and commingling (Step et al.,
2009) have been observed; however, high-risk, newly received stocker cattle are often
subjected to these stressors concurrently. Whereas, the negative effects of these stressors
are mitigated in cattle preconditioned on their origin ranch before marketing occurs (Duff
and Galyean, 2007). The most significant impact of physiological stress is the negative
effect it has on feed intake and immunocompetency (Loerch and Fluharty, 1999), both of
which may have a direct role in the development of BRD. Furthermore, acute infection
with respiratory viruses is more likely because stress-induced immunosuppression allows
viruses to evade host immune defense mechanisms (Sheridan et al., 1994).
Bovine viral diarrhea virus (BVDV) is a major culprit in the development of BRD
either directly via acute clinical disease or through indirect effects of immunosuppression
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(Welsh et al., 1995). Furthermore, calves born persistently infected (PI) with BVDV are a
key source of BVDV transmission (Fulton et al., 2005), and although prevalence of PIBVDV calves in the feedlot is estimated to be relatively low (0.3%; Loneragan et al.,
2005), a single PI-BVDV animal has the potential to continuously expose an entire pen
and adjoining pens to the virus. Although some have observed no overall differences in
health or performance of cohorts exposed to a PI-BVDV calf (Booker et al., 2008; Elam
et al., 2008), continuous exposure to PI-BVDV challenge may reduce growth
performance (Hessman et al., 2009) because repeated immune stimulation results in
nutrients being preferentially utilized for immune and homeostatic pathways rather than
tissue deposition (Klasing and Korver, 1997; Spurlock, 1997). We hypothesized that the
proinflammatory cytokine response would be altered by PI-BVDV exposure; however,
the magnitude of physiological alteration would be impacted by previous management.
The objective of our study was to determine the serum proinflammatory cytokine
concentration, total and differential blood leukocyte concentration, and rectal temperature
in commingled auction market vs. single-source preconditioned calves with or without
14-d continuous exposure to PI-BVDV challenge.
MATERIALS AND METHODS
Experimental Cattle
Animal methods and experimental procedures were approved by the University of
Arkansas Animal Care and Use Committee.
Two different cattle management sources were utilized for this 14-d evaluation
period; 1) a low-risk, single-source, preconditioned (PC) group of crossbred steer calves
(n = 27; initial BW = 282 ± 1.6 kg) from a single origin ranch located in Izard County,
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Arkansas and 2) a high-risk, commingled, auction market (AM) group of crossbred bull
(n = 15) and steer (n = 12) calves (initial BW = 268 ± 2.3 kg) acquired from an Arkansas
auction market. The PC steers arrived at the University of Arkansas Agricultural
Experiment Station located near Savoy (receiving unit; RU) on December 6, 2009 and
were considered to be low-risk for developing BRD because they had been previously
vaccinated against BRD pathogens, were weaned on their origin ranch for 61 d, and
maintained as a single-source without commingling. The AM calves were procured and
assembled by an order buyer from a public auction market located in North Central, AR
and arrived at the RU on December 5, 2009. The order buyer was instructed to purchase
AM cattle of similar BW and phenotype as the incoming PC calves. The AM cattle were
considered to be high-risk for developing BRD because they did not have known health
or vaccination history and were commingled extensively resulting in greater probability
of increased stress and exposure to BRD pathogens.
The main effects of cattle management (AM or PC) and PI-BVDV exposure (not
exposed = CON or exposed = PI) were tested in a 2 × 2 factorial arrangement resulting in
4 treatments. For PC treatments, 62 d prior to trial initiation, randomly selected steers
were weaned and confirmed free of PI-BVDV via ear-notch skin samples tested for the
presence of BVDV using the antigen-capture ELISA (ACE) method (Idexx Laboratories,
Inc., Westbrook, ME) at a commercial laboratory (Cattle Stats, LLC, Oklahoma City,
OK). Also on the day of weaning, PC calves were administered: 1) a 5-way modified-live
virus (MLV) respiratory vaccine containing infectious bovine rhinotracheitis, bovine viral
diarrhea virus type 1a and 2a, parainfluenza3, and bovine respiratory syncytial virus
isolates [Express 5, Boehringer Ingelheim Vetmedica (BIVI), St. Joseph, MO], 2)
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Manheimia haemolytica-Pastuerella multocida bacterin-toxoid (Pulmo-guard PHM-1,
BIVI), and 3) pour-on anthelmintic (Cydectin, BIVI). Fourteen-d later (d -48), PC calves
were administered a 7-way clostridial bacterin-toxoid (Alpha 7, BIVI) and re-vaccinated
with 5-way MLV respiratory vaccine. Preconditioned calves were isolated from other
cattle, fed hay or pasture along with a supplement, and remained on their origin ranch
during the preconditioning phase until d -1 when they were shipped to the RU.
Upon arrival to the RU, PC calves were maintained in an isolated holding pen
with ad libitum access to hay and water until treatment allocation on d 0. On d -1, PC
calves were weighed and returned to their isolated holding pen. The following d (d 0), PC
calves were weighed, bled via jugular venipunture into evacuated tubes (Vacutainer; BD
Inc, Franklin Lakes, NJ) to determine total and differential leukocytes (EDTA tube) and
serum proinflammatory cytokine concentrations (plain tube), stratified by d -1 BW, then
assigned randomly to treatment (PCCON or PCPI).
To coincide with PC, AM calves were assembled from a regional market and
delivered to the RU on d -2. Upon arrival to the RU, AM calves were maintained in an
isolated holding pen with ad libitum access to hay and water until treatment allocation on
d 0. On d -1, AM calves were weighed, identified with a unique ear identification tag, ear
notched to test for PI-BVDV status at a commercial laboratory (Cattle Stats) using the
ACE method (Idexx Laboratories), and returned to their isolated holding pen. On d 0,
AM cattle received the same vaccinations and processing procedures as described for PC
on their origin ranch; therefore, the first known processing for AM occurred on d 0 rather
than 62 d previously for PC. For AM calves only, re-vaccination of the 5-way MLV
respiratory vaccine (Express 5, BIVI) occurred on d 14 in addition to administration of a
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7-way clostridial bacterin-toxoid (Alpha 7, BIVI). Additionally on d 0, bull calves were
castrated surgically, stratified by gender and d -1 BW, then AM calves were assigned
randomly to treatment (AMCON or AMPI). Cattle were then moved to their randomly
assigned 3.7 × 29 m pens and provided 0.91 kg/d (as-fed basis) of a receiving supplement
(15.1% CP, DM basis) and ad libitum access to bermudagrass hay (13.1% CP, 52.3%
NDF, 40.6% ADF, DM basis) and water. Supplement offered was step-wise increased to
a maximum of 2.73 kg/d as each pen completely consumed the supplement offered for 2
consecutive d. All BW measurements were obtained individually without withholding
feed or water on 2 consecutive days at the beginning (d -1 and 0) and end (d 14 and 15)
of the receiving trial using a chute equipped with electronic load cells.
Leukocyte and Cytokine Analyses
Calves were bled on d 0, 1, 3, 5, 7, and 14 to determine interim total and
differential leukocytes. For each d, anticoagulated whole blood was collected from each
animal into EDTA tubes, kept refrigerated (5° C), and analyzed within 24 h to determine
percentage and concentrations (n cells/µL) of total and differential leukocytes
(lymphocytes, neutrophils, monocytes, eosinophils, and basophils), platelets, red blood
cells, hemoglobin, and hematocrit using an automated hemacytometer (Cell-Dyn 3500
system, Abbott Laboratories, Abbott Park, IL) standardized for analysis of bovine blood.
Equipment malfunction prohibited hematocrit and platelets from being analyzed on d 14.
Blood collected from each animal in plain evacuated tubes was centrifuged at
2,100 × g for 20 min at 20° C, and serum was decanted into duplicate aliquots and stored
frozen at -20° C. Subsequently, 5 sample aliquots were selected randomly on d 0, 1, 3, 7,
and 14 from each treatment pen and transported on ice to the USDA, ARS, National
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Animal Disease Center (NADC) in Ames, IA for determination of serum
proinflammatory cytokines TNF-α, IFN-γ, IL-4, and IL-6 using a custom bovine-specific
multiplex ELISA assay (SearchLight, Aushon Biosytems Inc., Billerica, MA) with an
intra- and interassay CV of 10% and 15%, respectively.
Rectal Temperature Evaluation and Treatment of BRD
Rectal temperature (RT) was recorded concurrent with blood sampling via a
digital thermometer (GLA Agricultural Electronics; San Luis Obispo, CA; readability = ±
0.1°C) and calves were considered morbid and treated with an antibiotic based solely on
RT. If RT was ≥ 40°C, calves were administered antibiotic therapy with enrofloxacin
(Baytril, Bayer Animal Health, Shawnee Mission, KS) at a dosage rate of 10 mg/kg of
BW, and immediately returned to their home pen. A 48 h post-treatment interval (PTI)
was implemented following administration of enrofloxacin, and a second RT was
recorded upon expiration of the initial antibiotic PTI. If the second RT was ≥ 40°C, a
second antibiotic treatment with florfenicol (Nuflor, Schering-Plough Animal Health,
Summit, NJ) was administered at a dosage rate of 40 mg/kg of BW. A 48 h PTI was also
implemented for cattle administered florfenicol, and RT was evaluated upon expiration of
the second antibiotic PTI. If the temperature was ≥ 40°C, a third and final antibiotic
treatment with ceftiofur HCl (Excenel RTU, Pfizer Animal Health, New York, NY) was
administered at a dosage rate of 2.2 mg/kg of BW and repeated for 2 consecutive days
following the initial injection of ceftiofur HCl. Treatment data were recorded for
individual animal including treatment date, RT, and the amount (mL) of each antibiotic
administered.
Persistently Infected Cattle
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Calves that had been previously ear-notched, tested at a commercial laboratory
(Cattle Stats), and identified as PI-BVDV according to ACE method were acquired from
a stocker cattle operation in Washington County, OK to be utilized as PI-BVDV exposure
sources. Upon arrival to the RU, each PI-BVDV calf was ear-notched a second time, and
samples were shipped via overnight parcel service to a different laboratory (NADC) for
rapid re-affirmation of positive PI-BVDV status using the same ACE procedure. The PIBVDV challenge calves were assigned randomly to 6 PI-designated pens. Additionally,
anticoagulated blood was collected from each PI-BVDV challenge animal and shipped on
ice via overnight parcel service to NADC for subsequent differentiation of BVDV
subgenotype strain using virus isolation of buffy coat cells and reverse-transcriptase PCR
analysis previously described by Ridpath and Bolin (1998). One PI-BVDV animal was
identified as subgenotype 1a, and the 5 remaining were subgenotype 1b. It is important to
note that BVDV 1b, the subgenotype strain in which the PI-BVDV calves used in this
experiment were identified, is the predominant BVDV subgenotype strain isolated from
cattle in the US (Fulton et al., 2002; Ridpath et al., 2010); however, currently no
commercial licensed MLV respiratory vaccine in the US contains a BVDV 1b isolate.
Pen Assignment and Arrangement
To avoid unwanted PI-BVDV fence-line contact with CON, receiving pens were
arranged spatially prior to treatment allocation. Pens measured 3.7 × 29 m, contained 3 m
of feed bunk-line and a fence-line water source shared with an adjacent pen of the same
treatment. Furthermore, the treatment pens were configured so that unlike treatment pens
were separated by at least 1 unoccupied pen. Within management source, calves were
stratified by gender (AM only) and d -1 BW, then assigned randomly to 1 of 6 PI or CON
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pens. For PI treatments, a PI-BVDV challenge animal was assigned randomly to each PIdesignated treatment pen such that pens had an equivalent number of cattle. During all
bleeding procedures, CON treatments were evaluated first, followed by PI treatments to
avoid unwanted CON contact with PI challenge animals or experimental cattle in the PI
treatments, and to reduce possible exposure to fomites contaminated with secretory fluid
or fecal material containing BVDV.
Statistical Analyses
Performance data were analyzed as a randomized complete block design using the
MIXED procedure of SAS (SAS Inst., Inc., Cary, N.C.). Pen was considered the
experimental unit. The class statement included treatment and replicate. Replicate was
considered a random effect in the statistical model. Single degree of freedom orthogonal
contrasts evaluating effects of management (PC or AM), exposure (PI or CON), and their
interaction were used. If the interaction was significant (P ≤ 0.10), treatment means were
separated with a t-test using the PDIFF option in SAS. For main effects of management
and exposure, a P-value ≤ 0.05 was considered statistically significant. For morbidity
data, the class statement included treatment and pen. Pen was considered a random effect.
For repeated measures data, the model included treatment, day, and treatment × day.
Kenward Roger was specified as the degrees of freedom selection method. Treatment,
day, replicate, pen and animal were used in the class statement. Replicate was the random
variable, animal was the subject, and the repeated statement was day. The covariance
model structure used was SP(POW). Contrasts for the repeated measures data included
management, exposure, and management × exposure interaction.
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RESULTS AND DISCUSSION
Rectal Temperature
Mean RT for AM calves increased sharply (treatment × day interaction; P <
0.001) upon trial initiation and remained elevated until reaching baseline on d 14 such
that a main effect of management (P < 0.001) was evident (Figure 1). Febrile RT
responses have been consistently reported in experimental models of viral (Chirase et al.,
1991; Muller-Doblies et al., 2004), endotoxin (Reuter et al., 2008) and corticotrophinrelease hormone (Cooke and Bohnert, 2011) challenge. Furthermore, RT ≥ 40°C is a
standard objective index used to determine clinical BRD morbidity of cattle both in the
production setting (Edwards, 2010) and in the current study. Peak RT was observed on d
1, averaging 40.3 and 39.1°C for AM and PC, respectively. The elevated RT in AM
corresponded with markedly greater (management effect; P < 0.001) morbidity for AM
(86%) vs. PC (4%) during the 14-d evaluation period; consequently, antibiotic treatment
cost was $23.25 vs. $1.53/animal for AM and PC, respectively.
The greater RT observed for AM may be in response to physiological stress,
disease pathogens, or both; however differentiation of the febrile response is difficult to
determine. Nevertheless, PI-BVDV challenge did not affect (P = 0.95) RT in our study;
thus, the increased rectal temperature observed for AM but not PC treatments was likely
due to greater physiological stress or acute effects of viral or bacterial pathogens
encountered by AM cattle during the marketing process. Others reported RT being
increased subsequent to PI-BVDV challenge (Burciaga Robles et al., 2010) or oral
inoculation of BVDV (Muller-Doblies et al., 2004); however, the sampling intervals were
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earlier and more concerted in these studies and differences in RT that may have occurred
between sampling intervals in the current study are unknown.
Total and Differential Leukocytes
A main effect of management (P = 0.01) and a treatment × day interaction (P <
0.001) was evident for total leukocytes (Figure 2). Total leukocytes were less for AM
cattle (management effect; P = 0.01) whereas, AMCON had the lowest concentration of
circulating leukocytes on d 5, 7, and 14 (trt × day; P ≤ 0.05). Total leukocytes did not
differ (P = 0.17) for PI compared to CON. In a previous study, total leukocytes were
reduced in steers exposed to PI-BVDV challenge only, yet total leukocytes were
increased when concurrently challenged with M. haemolytica (Burciaga-Robles et al.,
2010). A frequent outcome of stress- or viral-induced immunosuppression is severe or
fatal bacterial pneumonias (Panciera and Confer, 2010). However, the degree to which
experimental animals in the current study were infected with pathogenic bacteria such as
M. haemolytica, and potentially confounding affects on leukocyte concentrations was
unknown.
The percentage of neutrophils were less (P = 0.01; Figure 3), and the percentage
of lymphocytes greater (P = 0.02; Figure 4) in calves exposed to PI-BVDV challenge
than CON. Consequently, a trend (P = 0.07) was observed for neutrophil:lymphocyte
(N:L) ratio (Figure 5) being less in calves exposed to a PI-BVDV calf. Similarly,
Burciaga-Robles (2010) reported neutrophils were less in steers exposed to PI-BVDV
challenge only; however, when PI-exposed steers were challenged with M. haemolytica,
neutrophils were increased. In our study, cattle management also affected (P = 0.02) N:L
ratio; AM calves had greater N:L ratio than PC. Although neutrophils were not reported,

129

Gupta et al. (2005) observed decreased lymphocytes after steers were subjected to 6
regrouping and repenning events intended to induce physiological stress. Other studies
reported transient increases in N:L for cattle experiencing transport (Kegley et al., 1997;
Ishizaki and Kariya, 2010), weaning (Hickey et al., 2003), and commingling (McGlone et
al., 1993) stress. Therefore, the increased N:L ratio would indicate greater stress for AM
compared to PC.
On d 3, the percentage of monocytes was greatest for AMCON, intermediate for
AMPI, and least for PCCON and PCPI (Trt × day; P = 0.01). A treatment × day
interaction (P < 0.001) was observed for platelet concentrations. On d 1, platelets were
greatest for PCPI, intermediate for PCCON and AMPI, and least for AMCON (P ≤ 0.05;
Figure 6). However, on d 7 this pattern was inverted; AMPI had the greatest platelets,
AMCON was intermediate, and PCPI and PCCON were least (P ≤ 0.05). Platelets are
well known for their role in inflammation and hemostasis (George, 2000); however, their
function and response to disease challenge or physiological stress are less clear. Sowa et
al. (2009) proposed platelets as a potential modulator of adaptive immunity because they
may enhance antigen presentation. Further investigation on the platelet response to
physiological stress and disease in beef cattle seems warranted.
Serum Cytokines
Serum TNF-α concentration tended (P = 0.09) to be greater in calves exposed to
PI-BVDV challenge (Figure 7). There were no main effects of cattle management on
serum proinflammatory cytokine concentrations in the current study. Day effects (P ≤
0.001) were observed for TNF-α, IFN-γ, IL-4 and IL-6; concentrations increased
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transiently with time. Other than a day effect, no differences were observed for serum IL4 concentration (Figure 9).
A treatment × day interaction was observed for concentrations of IFN-γ (P =
0.05) and IL-6 (P = 0.006; Figure 8 and 10, respectively). Peak IFN-γ concentrations
occurred on d 7 and were 3.3-fold greater in AMPI than PCCON (P = 0.004). By d 14,
overall IFN-γ concentrations had decreased (day effect; P = 0.001); nevertheless, AMPI
was greatest, PCPI was intermediate, and AMCON and PCCON were least.
Peak concentrations of IL-6 were observed on d 1 and rapidly returned to near
baseline levels by d 3; nevertheless, a treatment × day interaction (P = 0.006) was
evident. On d 1, IL-6 concentrations were greatest for AMCON, intermediate for AMPI
and PCPI, and least in PCCON. By d 14, AMPI had greater serum concentrations of IL-6
compared to AMCON.
Similar to our results of increased TNF-α, IFN-γ and IL-6 for PI-exposed
treatments, Burciaga-Robles et al. (2010) observed increases in TNF-α, IFN-γ, and IL-6
when steers were exposed 72 h to 2 PI-BVDV calves. Carroll et al. (2009) observed that
both TNF-α and IL-6 concentrations increased following endotoxin challenge in calves,
and the magnitude of increase was greater for calves weaned at 250 d of age versus
early-weaned at 80 d of age and shipped simultaneously to a receiving facility.
Proinflammatory cytokine concentrations being greater for AMPI and PCPI suggests a
more stimulated immune response via continuous PI-BVDV exposure that may
consequently affect growth performance (Spurlock, 1997). Although differences in
growth were not observed in this 14-d trial, evidence from a companion study (Chapter
V) suggests that effects of PI-BVDV exposure are often sub-acute, and consequences on
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growth performance may be delayed for several weeks, beyond the 14-d evaluation
period herein.
In conclusion, continuous PI-BVDV exposure may decrease growth performance
because the repeated immune stimulation increases proinflammatory cytokines IFN-γ,
TNF-α, and IL-6 that can impair growth either directly by acting on tissues, or indirectly
through their effects on the endocrine system (Klasing and Korver, 1997). Differences in
hematological variables, particularly neutophil:lymphocyte ratio, may also indicate
differences in physiological stress and disease in newly received beef calves.
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Figure 1. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on mean rectal temperature of newly received beef calves. Effect of
treatment × day (P < 0.001), day (P < 0.001), and management (P < 0.001). Means
within a day without a common superscript differ (P ≤ 0.05). AMCON = auction market,
control; AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON =
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV
exposure.
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Figure 2. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on blood leukocyte concentrations of newly received beef calves. Effect
of treatment × day (P < 0.001), day (P = 0.005), and management (P = 0.01). Means
within a day without a common superscript differ (P ≤ 0.05). AMCON = auction market,
control; AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON =
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV
exposure.
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Figure 3. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on percent neutrophils in blood of newly received beef calves. Effect of
treatment × day (P < 0.001), day (P < 0.001), and exposure (P = 0.01). A tendency (P =
0.07) was observed for management effect. Means within a day without a common
superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI = auction
market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, control;
PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 4. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on percent lymphocytes in blood of newly received beef calves. Effect of
treatment × day (P < 0.001), day (P < 0.001), and exposure (P = 0.02). A tendency (P =
0.10) was observed for management effect. Means within a day without a common
superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI = auction
market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, control;
PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 5. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on blood neutrophil:lymphocyte ratio of newly received beef calves.
Effect of treatment × day (P < 0.001), day (P < 0.001), and management (P = 0.02). A
tendency (P = 0.07) was observed for management effect. Means within a day without a
common superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI =
auction market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned,
control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 6. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on blood platelet concentration of newly received beef calves. Effect of
treatment × day (P < 0.001) and day (P < 0.001). Means within a day without a common
superscript are different (P ≤ 0.05). AMCON = auction market, control; AMPI = auction
market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, control;
PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 7. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum tumor necrosis factor-α concentration of newly received beef
calves. Day effect (P < 0.001). A tendency (P = 0.09) was observed for an exposure
effect. AMCON = auction market, control; AMPI = auction market, exposed to
continuous PI-BVDV challenge; PCCON = preconditioned, control; PCPI =
preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 8. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum interferon-γ concentration of newly received beef calves. Effect
of treatment × day (P = 0.05) and day (P = 0.001). Means within a day without a
common superscript are different (P ≤ 0.05). AMCON = auction market, control; AMPI
= auction market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned,
control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 9. Effects of weaning management and persistently infected bovine viral diarrhea
virus challenge on serum interleukin-4 concentration of newly received beef calves. Day
effect (P < 0.001). AMCON = auction market, control; AMPI = auction market, exposed
to continuous PI-BVDV challenge; PCCON = preconditioned, control; PCPI =
preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 10. Effects of weaning management and persistently infected bovine viral
diarrhea virus challenge on serum interleukin-6 concentration of newly received beef
calves. Effect of treatment × day (P = 0.006) and day (P < 0.001). Means within a day
without a common superscript are different (P ≤ 0.05). AMCON = auction market,
control; AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON =
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV
exposure.
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CHAPTER VII

CONCLUSION
A series of experiments were conducted to determine the effects of on-arrival vs.
delayed respiratory vaccination and exposure to persistently infected bovine viral
diarrhea virus challenge on health, gain performance, and physiological and
immunological measurements in newly received stocker cattle. Two experiments
evaluated timing (d 0 vs. 14) of respiratory, clostridial, or both vaccinations in newly
received stocker calves during stress-induced immunosuppression. In Exp. 1, calves
receiving 14-d delayed vaccination of a pentavalent modified-live respiratory virus
(MLV) vaccine had greater ADG during the 42-d receiving period and antibody titers
against infectious bovine rhinotracheitis on d 42; however, morbidity rate did not differ.
In the second study, stress indicated by serum cortisol concentration and
neutrophil:lymphocyte ratio was greatest on d 0; nevertheless, no differences in
performance or morbidity were observed for vaccination treatments. Both studies
provided evidence that on-arrival administration of a pentavalent MLV respiratory
vaccine to immunocompromised cattle does not mitigate clinical bovine respiratory
disease (BRD) or improve animal performance because the majority of clinical
respiratory disease for both studies occurred during the first 14-d and morbidity rate was
not different when calves were vaccinated on d 0 vs. 14.
A third trial was performed to determine the effects of weaning management and
subsequent exposure to persistently infected (PI) bovine viral diarrhea virus (BVDV)
challenge on health, performance, bovine viral diarrhea virus titers, peripheral blood
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leukocytes, and inflammatory cytokines. The objective was to compare treatments of
preconditioned (PC) or auction market (AM) origin, with (PI) or without (CON)
continuous exposure to PI-BVDV type 1b challenge in a 2 × 2 factorial arrangement to
evaluate main effects of management, exposure, and their interaction on health
parameters and growth performance during a 42-d receiving trial. Preconditioned calves
that were vaccinated, castrated, and weaned at their origin ranch had greater gain
performance and reduced BRD morbidity compared to AM calves with unknown history.
Furthermore, PC cattle had greater antibody titers to BVDV type 1a on d 0, and
neutrophil:lymphocyte ratio and platelet count were lower during the 42-d receiving
period. Exposure to PI-BVDV challenge reduced gain from d 28 to 42, perhaps due to an
additive effect of continuous immune stimulation resulting in nutrients being
preferentially utilized for immune pathways rather than tissue deposition. A treatment
interaction was observed for the percentage of chronically ill animals; AMPI had the
greatest number of chronically ill calves (7.6%), AMCON was intermediate (1.1%), and
PCCON and PCPI were least (0.4 and 0.3%, respectively). These results would suggest
that costs incurred for labor, shipping, laboratory testing of ear-notch samples, and
removal of animals identified as PI-BVDV may not overcome losses in health or
performance of single-source, PC calves during the receiving period. However, high-risk,
commingled, AM cattle that are naïve and experiencing physiological stress and
immunosuppression may warrant testing and removal of PI-BVDV animals.
During a 14-d evaluation period (trial 4), exposure to PI-BVDV challenge
increased serum TNF-α concentrations, and IFN-γ concentrations on d 14 were greatest
for AMPI, intermediate for PCPI, and least for AMCON and PCCON. The increased
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cytokine concentrations associated with PI-BVDV exposure illustrate a more stimulated
immune response which has implications for animal health due to taxation of the immune
system and growth due to a homeorhetic response in which nutrients may be
preferentially shifted towards immune function rather than tissue growth.
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